0001493152-16-015332.txt : 20161121 0001493152-16-015332.hdr.sgml : 20161121 20161121160606 ACCESSION NUMBER: 0001493152-16-015332 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 61 CONFORMED PERIOD OF REPORT: 20160930 FILED AS OF DATE: 20161121 DATE AS OF CHANGE: 20161121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KIWA BIO-TECH PRODUCTS GROUP CORP CENTRAL INDEX KEY: 0001159275 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 870448400 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-33167 FILM NUMBER: 162010398 BUSINESS ADDRESS: STREET 1: 310 N. INDIAN HILL BOULEVARD STREET 2: SUITE 702 CITY: CLAREMONT STATE: CA ZIP: 91711 BUSINESS PHONE: 626-715-5855 MAIL ADDRESS: STREET 1: 310 N. INDIAN HILL BOULEVARD STREET 2: SUITE 702 CITY: CLAREMONT STATE: CA ZIP: 91711 FORMER COMPANY: FORMER CONFORMED NAME: TINTIC GOLD MINING CO DATE OF NAME CHANGE: 20010918 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X]	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2016

[ ]	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ____________ to ____________

Commission File Number: 000-33167

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

(Exact name of registrant as specified in its charter)

Delaware		77-0632186
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

310 N. Indian Hill Blvd., #702 Claremont, California		91711
(Address of principal executive offices)		(Zip Code)

(626) 715-5855

(Registrant’s telephone number, including area code)


	(Former address)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]		Accelerated filer [ ]
Non-accelerated filer [ ]		Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

There were 8,603,981 shares of the issuer’s common stock outstanding as of November 18, 2016.

Table of contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements	3

Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	14

Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	18

Item 4. Controls and Procedures	18

PART II. OTHER INFORMATION	18

Item 1. Legal Proceedings	18

ITEM 1A. RISK FACTORS	18

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	19

Item 3. Defaults Upon Senior Securities	19

Item 4. Mine safety disclosures	19

Item 5. Other Information	19

Item 6. Exhibits	19

SIGNATURES	20

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

CONSOLIDATED BALANCE SHEETS

(Unaudited)

	September 30, 2016			December 31, 2015

ASSETS
Current assets
Cash and cash equivalents	$	545		$	721
Accounts receivable		1,224,410			-
Prepaid expenses		1,639,583			-
Advance to customer - Gerui		1,677,459			-
Other current assets		58,432			47,453
Total current assets		4,600,429			48,174
Property, plant and equipment - net		69,652			2,807
Rent and utility deposits		37,295			-
Intangible assets		34,112			-
Total assets	$	4,741,488		$	50,981
LIABILITIES AND STOCKHOLDERS’ DEFICIENCY
Current liabilities
Accounts payable	$	1,076,266		$	300,247
Advances from customers		13,415			13,800
Construction costs payable		266,103			273,722
Due to related parties - trade		1,337,489			1,143,978
Due to related parties - non-trade		107,710			3,166,198
Convertible notes payable		150,250			150,250
Notes payable		360,000			360,000
Salary payable		1,675,900			1,632,881
Taxes payable		586,958			478,209
Penalty payable		462,423			404,752
Interest payable		1,014,480			930,062
Other payable		479,659			-
Accrued expenses and other current liabilities		512,003			524,205
Total current liabilities		8,042,656			9,378,304

Unsecured loans payable		1,723,776			1,773,131
Total long-term liabilities		1,723,776			1,773,131
Total liabilities		9,766,432			11,151,435

Stockholders’ deficiency
Preferred stock - $0.001 par value. Authorized 20,000,000 shares. Issued outstanding 500,000 shares at September 30, 2016 and December 31, 2015, respectively		500			500
Common stock - $0.001 par value. Authorized 100,000,000 shares. Issued and outstanding 8,603,981 and 2,000,000 shares at September 30, 2016 and December 31, 2015, respectively.		8,604			2,000
Additional paid-in capital		15,684,507			9,490,837
Stock subscription receivable		(560,341	)		-
Accumulated deficit		(19,993,105	)		(20,324,812	)
Accumulated other comprehensive loss		(165,109	)		(268,979	)
Total stockholders’ deficiency		(5,024,944	)		(11,100,454	)
Total liabilities and stockholders' deficiency	$	4,741,488		$	50,981

The accompanying notes are an integral part of these consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited)

	Three Months Ended September 30,						Nine Months Ended September 30,
	2016			2015			2016			2015
				<Restated>						<Restated>
Revenue	$	1,261,544		$	-		$	1,971,639		$	-
Cost of revenue		(770,451	)		-			(770,451	)		-
Gross profit		491,093			-			1,201,188			-

Operating expenses
General and administrative		196,019			72,968			421,688			220,510
Research and development		74,783			39,860			226,552			121,487
Total operating expenses		270,802			112,828			648,240			341,997
Operating income (loss)		220,291			(112,828	)		552,948			(341,997	)

Other expense
Penalty expense		19,564			18,208			57,672			53,605
Interest expense		28,181			28,189			84,624			84,449
Total other expense		47,745			46,397			142,296			138,054
Income (loss) before income tax provision		172,546			(159,225	)		410,652			(480,051	)
Income tax provision		78,945			-			78,945			-
Net income (loss)		93,601			(159,225	)		331,707			(480,051	)

Other comprehensive income
Foreign currency translation adjustment		9,765			327,472			103,870			278,566
Comprehensive income (loss)	$	103,366		$	168,247		$	435,577		$	(201,485	)

Net income(loss) per common share - basic	$	0.01		$	(0.08	)	$	0.07		$	(0.24	)
Net income(loss) per common share - diluted	$	0.01		$	(0.08	)	$	0.04		$	(0.24	)
Weighted average number of common shares outstanding - basic		6,300,700			2,000,000			4,617,535			2,000,000
Weighted average number of common shares outstanding - diluted		7,064,969			2,000,000			7,769,954			2,000,000

The accompanying notes are an integral part of these consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended September 30,
		2016			2015
					<Restated>
Cash flows from operating activities:
Net income (loss)		$	331,707		$	(480,051	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization			13,039			3,293
Provision for penalty payable			57,672			53,605
Accrued interest on convertible notes			84,418			84,357
Issuance of common shares for service			57,717			-
Changes in operating assets and liabilities:
Accounts receivable			(1,240,550	)		-
Prepaid expenses			(7,500	)		-
Advance to customer - Gerui			(1,700,605	)		-
Other current assets			(11,988	)		-
Rent and utility deposits			(37,809	)		-
Salary payable			93,993			110,604
Taxes payable			123,604			47,604
Due to related parties - trade			226,392			121,487
Accounts payable			794,868			-
Other payable			477,284			(18,752	)
Net cash used in operating activities			(737,758	)		(77,853	)

Cash flows from investing activities:
Purchase of property, plant and equipment			(79,604	)		-
Net cash used in investing activities			(79,604	)		-

Cash flows from financing activities:
Proceeds from related parties, net of payments to related parties			51,500			77,988
Proceeds from sale of common stock			766,281			-
Net cash provided by financing activities			817,781			77,988
Effect of exchange rate change			(595	)		(18	)

Cash and cash equivalents:
Net increase (decrease)			(176	)		117
Balance at beginning of period			721			2,963
Balance at end of period		$	545		$	3,080

Non-cash financing activities:
Issuance of 3,141,000 shares of common stock for repayment of related party loans		$	3,141,000		$	-
Issuance of 101,947 shares of common stock for payment of accrued salaries		$	50,974		$	-
Issuance of 1,710,808 shares of common stock for prepaid consulting services		$	1,630,583		$	-
Advances from related parties to pay for acquisition of intangible assets		$	34,112		$	-

Supplemental Disclosures of Cash flow Information:
Cash paid for interest		$	-		$	-
Cash paid for income taxes		$	-		$	-

The accompanying notes are an integral part of these consolidated financial statements.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Description of Business and Organization

References herein to “Kiwa” or the “Company” refer to Kiwa Bio-Tech Products Group Corporation and its wholly-owned subsidiaries unless the context specifically states or implies otherwise.

Business –The Company’s business is to develop, manufacture, distribute and market innovative, cost-effective and environmentally safe bio-technological products for agriculture markets located primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.

Acquisition of Caber Holdings Ltd - On November 30, 2015, we entered into an acquisition agreement (the “Agreement”) with the shareholders of Caber Holdings LTD, whose Chinese name is Hong Kong Baina Group Co., Ltd, located in Hong Kong (“Baina Hong Kong”), and Oriental Baina Co. Ltd. (hereinafter referred to as “Baina Beijing”), Baina Hong Kong’s wholly-owned subsidiary in Beijing, China. Kiwa will rename Baina Beijing to Kiwa Baiao Co. Ltd. Kiwa Baiao Co. Ltd will replace Kiwa’s current subsidiary in China - Kiwa Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”) - to operate Kiwa’s bio-fertilizer market expansion and become Kiwa’s platform for future acquisitions of new agricultural-related projects in China. In accordance with the terms of the Agreement, Kiwa agreed to pay US$30,000 to the Baina Hong Kong Shareholders for the acquisition of 100% of the equity of Baina Hong Kong. The acquisition was completed on January 7, 2016. Both Baina Hong Kong and Baina Beijing had no activities before the acquisition date and had no assets and liabilities. The purpose of this acquisition was to acquire Baina Hong Kong’s corporate registration in Hong Kong and in China. The total payment of approximately $34,000 was recorded as intangible assets.

Restatement - Based on the previously restated consolidated financial statements for the year ended December 31, 2014 which were filed with company’s annual report Form 10K for the year ended December 31, 2015, the management of the Company has concluded that consolidated statement of comprehensive income (loss) for the three and nine months ended September 30, 2015 should be restated to record accrued interest expense of $22,500 and $67,500 respectively. (see Note 9)

2. Going Concern

The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not purport to represent the realizable or settlement values.

As of September 30, 2016, the Company had cash of $545. The Company had working capital deficit of $3,442,227 and an accumulated deficit of $ 19,993,105 and a stockholders’ deficiency of $5,024,944 as of September 30, 2016. This trend is expected to continue. These factors, among others, create substantial doubt about the Company’s ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

The Company plans to (1) raise finance from related-parties, local banks, other financial institutions and other stock market to meet cash demand of daily demand; and (2) raise capital to resume operations. However, there can be no assurance that we will be successful in obtaining this financing (3) The Company’s business plan is to develop, manufacture, distribute and market innovative, cost-effective and environmentally safe biotechnological products for agriculture markets located primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.

3. Summaries of Significant Accounting Policies

Principle of consolidation - These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant inter-company balances or transactions are eliminated on consolidation.

Basis of preparation - These interim consolidated financial statements are unaudited. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year or any other periods. The (a) consolidated balance sheet as of December 31, 2015, which was derived from audited financial statements, and (b) the unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Reverse Split - On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Company’s authorized capital stock was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.

Use of Estimates - The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the bad debt provision, impairment of long-lived assets, depreciation and amortization, valuation allowance of deferred tax assets and fair value of warrants and options.

Foreign Currency Translation - The Company uses United States dollars (“US Dollar” or “US$” or “$”) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (“RMB”), being the primary currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of income is translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Company’s financial statements are recorded as accumulated other comprehensive income.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:

			As of September 30, 2016				As of December 31, 2015
Balance sheet items, except for equity accounts			US$1 = RMB 6.6714				US$1 = RMB 6.4857

	Nine months ended September 30,
	2016	2015
Items in the statements of income and cash flows	US$1 = RMB 6.5806	US$1 = RMB 6.1735

Impairment of Long-Lived Assets - We periodically evaluate our investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Our judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, we make assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets. Based on our analysis, no further impairment of long-lived assets was charged during the nine months ended September 30, 2016.

Revenue Recognition - The Company’s revenue includes two parts: Part I represents fees per licensing agreement. The Company entered into an agreement with a company, Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (“Gerui”), to allow Gerui sell products with the Company’s trademark. Gerui will pay 10% of total sales amount to the Company as license fee.

Part II represents the revenues from sales of products purchased. The Company recognized license fees and revenue from sales of products when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, and no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as advances from customers.

Accounts Receivables - Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Income Taxes - The Company accounts for income taxes under the provisions of FASB ASC Topic 740, “Income Tax,” which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.

Fair value measurements - ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying values of cash and cash equivalents, trade receivables and payables, and short-term debts approximate their fair values due to their short maturities.

There were no assets and liabilities measured at fair value on a nonrecurring basis as of September 30, 2016 and December 31, 2015.

4. Prepaid expenses

The Company issued 1,710,808 shares of common stock to three consulting companies for the investor relation consulting service and four individuals for the growth and development strategy consulting service in China, which represents the amount of $1,688,300 based on quoted price at issuance. The Company amortized the consulting fee over the service periods per agreements. For the nine months ended September 30, 2016, the amortization of consulting expense was $57,717.

5. Advance to customer - Gerui

As of September 30, 2016, Advance to customer-Gerui was $1,677,459, which represents the prepayment to Gerui, the main customer, to subcontract the manufacturing of products to an unrelated company, Shandong Deluke Company.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

6. Related Party Transactions and Balances

Amounts due to related parties consisted of the following:

Item

Nature

Notes

September 30, 2016

December 31, 2015

Mr. Wei Li (“Mr. Li”)

Non-trade

(1)

2,879,307

Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. (“Kangtai”)

Non-trade

(2)

(12,173

)

Ms. Yvonne Wang (“Ms. Wang”)

Non-trade

(3)

107,710

299,064

Subtotal

107,710

3,166,198

Kiwa-CAU R&D Center

Trade

(4)

1,206,644

1,125,553

CAAS IARRP and IAED Institutes

Trade

(5)

130,845

18,425

Subtotal

1,337,489

1,143,978

Total

1,445,199

4,310,176

(1) Mr. Li

Mr. Li was the Chairman of the Board until November 20, 2015 and was the Chief Executive Officer of the Company until July 1, 2015.

Advances and Loans

As of December 31, 2015, the remaining balance due Mr. Li was 2,879,307. During the nine months ended September 30, 2016, Mr. Li received 2,900,000 shares of common stock in lieu of the cancellation and repayment of an aggregate of $2,879,307 and salary payable.

Guarantees for the Company

Mr. Li has pledged without any compensation from the Company, all of his common stock of the Company as collateral security for the Company’s obligations under the 6% Notes. (See Note 8 below).

(2) Kangtai

Kangtai, formerly named Kangtai International Logistics (Beijing) Co., Ltd., Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd., is a private company, 28% owned by Mr. Li. Mr. Li is the Chairman of Kangtai.

On December 31, 2015, the amount due from Kangtai was $12,173. The balance due from Kangtai on September 30, 2016 was nil.

(3) Ms. Wang

Ms. Wang is the Secretary of the Company until November 20, 2015. Effective as of November 20, 2015, the Company appointed Ms. Wang as the Chairman of the Board. Effective as of December 15, 2015, the Company appointed Ms. Wang as the Company’s Chief Operating Officer.

On December 31, 2015, the amount due to Ms. Wang was $299,064. On March 24, 2016, the Company issued 240,000 shares of common stock to Ms. Wang to pay off the loan balance of $240,000. During the nine months ended September 30, 2016, Ms. Wang paid various expenses on behalf of the Company. As of September 30, 2016, the amount due to Ms. Wang was $107,710.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(4) Kiwa-CAU R&D Center

Pursuant to the agreement with China Agricultural University (“CAU”), the Company agree to invest RMB 1 million (approximately $160,000) each year to fund research at Kiwa-CAU R&D Center. Prof. Qi Wang, one of the Company’s directors, is also the director of Kiwa-CAU R&D Center.

On December 31, 2015, the amount due to Kiwa-CAU R&D Center was $1,125,553. As of September 30, 2016, the outstanding balance due to Kiwa-CAU R&D Center was $1,206,644.

(5) CAAS IARRP and IAED Institutes

On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.

On December 31, 2015, the amount due to Kiwa- CAAS IARRP and IAED Institutes R&D Center was $18,425. As of September 30, 2016, the outstanding balance due to Kiwa-CAAS IARRP and IAED Institutes R&D center was $130,845.

7. Other Payable

Other payable includes the payables to two potential investors and subscription received in advance. As of September 30, 2016, those two potential investors made the first payments of $479,659 to the Company and the investment agreements haven’t been reached yet. Those two potential investors are non-related parties.

8. Convertible Notes Payable

Convertible notes payable consists of 6% secured convertible notes issued to FirsTrust Group Inc. on June 29, 2006. The notes beard interest at 6% and were due on June 29, 2009. Once the note is pass due, the interest rate increased to 15% per annum. The Company accrued $16,919 and $16,857 interest expense on convertible notes for the nine months ended September 30, 2016 and 2015, respectively.

The conversion price of the 6% Notes is based on a 40% discount to the average of the trading price of the Company’s common stock on the OTC Bulletin Board over a 20-day trading period. The conversion price is also adjusted for certain subsequent issuances of equity securities of the Company at prices below the conversion price then in effect. The 6% Notes contain a volume limitation that prohibits the holder from further converting the 6% Notes if doing so would cause the holder and its affiliates to hold more than 4.99% of the Company’s outstanding common stock. In addition, the holder of the 6% Notes agrees that they may not convert more than their pro-rata share (based on original principal amount) of the greater of $120,000 principal amount of the 6% Notes per calendar month or the average daily dollar volume calculated during the 10 business days prior to a conversion, per conversion. This conversion limit has since been eliminated pursuant to an agreement by the Company and the Purchasers.

The Company incurs a financial penalty in cash or shares at the option of the Company (equal to 2% of the outstanding amount of the Notes per month plus accrued and unpaid interest on the Notes, prorated for partial months) if it breaches this or other affirmative covenants in the Purchase Agreement, including a covenant to maintain a sufficient number of authorized shares under its Certificate of Incorporation to cover at least 110% of the stock issuable upon full conversion of the Notes. Pursuant to the relevant provisions for liquidated damages in the Purchase Agreement, the Company has accrued the penalty of $57,672 and $53,605 for the nine months ended September 30, 2016 and 2015, respectively.

The 6% Notes require the Company to procure the Purchaser’s consent prior to taking certain actions including the payment of dividends, repurchasing stock, incurring debt, guaranteeing obligations, merging or restructuring the Company, or selling significant assets.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The Company’s obligations under the 6% Notes are secured by a first priority security interest in the Company’s intellectual property pursuant to an Intellectual Property Security Agreement with the Purchasers, and by a first priority security interest in all of the Company’s other assets pursuant to a Security Agreement with the Purchasers. In addition, Mr. Li, the Company’s Chief Executive Officer until July 1, 2015, has pledged all of his common stock of the Company as collateral for the Company’s obligations under the 6% Notes. The intellectual property pledged had a cost of $592,901 which carrying value of $179,897 was fully impaired during the year ended December 31, 2009.

9. Note payable

On May 29, 2007, the Company issued a $360,000 promissory note to an unrelated individual. This note bears interest at 18% per annum and was due on July 27, 2007. This note is currently in default and bears interest of 25% per annum (the “Default rate”) until paid in full. This note is secured by a pledge of 6,178,336 (post-reverse split 30,892) shares of the Company’s common stock owned by Investlink (China) Limited, a British Virgin Island corporation. The Company accrued $67,500 and $67,500 interest expense on note payable for the nine months ended September 30, 2016 and 2015, respectively.

10. Stockholders’ Equity

During the nine months ended September 30, 2016, the Company issued 3,140,000 shares of common stock to Mr. Li and Ms. Wang for debt repayment and salary payment for an aggregate amount of $3,141,000 (See Note 6).

The Company issued 1,650,000 shares of common stock to sixteen individual shareholders at $0.8 per share for an aggregate amount of $1,320,000 during the nine months ended September 30, 2016, $560,341 of which has not been received by the Company as of September 30, 2016 and has been recorded in the account of stock subscription receivable.

During the nine months ended September 30, 2016, the Company issued 1,710,808 shares of common stock to three consulting companies for the investor relation consulting service and four individuals for the growth and development strategy consulting service in China, which represents the amount of $1,688,300 based on quoted price at issuance. The Company amortized the consulting fee over the service periods per agreements. For the nine months ended September 30, 2016, the amortization of consulting expense was $57,717.

The Company also issued 101,947 shares of common stock to Jimmy Zhou, prior CEO of the Company, to settle the partial salary payable of $50,974 owed to Jimmy Zhou in August, 2016.

11. Stock-based Compensation

On December 12, 2006, the Company granted options for 2,000,000 shares of its common stock under its 2004 Stock Incentive Plan. Summary of options issued and outstanding at September 30, 2016 and the movements during the nine months then ended are as follows:

	Number of underlying shares		Weighted- Average Exercise Price Per Share		Aggregate Intrinsic Value (1)		Weighted- Average Contractual Life Remaining in Years
Outstanding at December 31, 2015		6,163	$	35	$	-		1
Exercised		-		-
Expired		-		-		-
Forfeited		-		-		-
Outstanding at September 30, 2016		6,163	$	35	$	-		0.25

Exercisable at September 30, 2016		6,163	$	35	$	-		0.25

(1)	The market value of the Company’s common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

12. Commitments and Contingencies

The Company has the following material contractual obligations:

Operation of Kiwa-CAU R&D Center

Pursuant to the agreement on joint incorporation of the research and development center between CAU and Kiwa Shandong dated November 14, 2006, Kiwa Shandong agrees to invest RMB1 million (approximately $160,000) each year to fund research at the R&D Center. The term of this Agreement is ten years starting from July 1, 2006. Qi Wang, one of our directors commencing in July 2007 has acted as Director of Kiwa-CAU R&D Center since July 2006.

CAAS IARRP and IAED Institutes

On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 Million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.

Investment in manufacturing and research facilities in Zoucheng, Shandong Province in China

According to the Project Agreement with Zoucheng Municipal Government in 2002, the Company has committed to investing approximately $18 million to $24 million for developing the manufacturing and research facilities in Zoucheng, Shandong Province. The Company had invested approximately $2 million for the project during the period from 2004 to 2010 and no additional investments were made since then.

13. Income Tax

In accordance with the current tax laws in China, the company’s subsidiaries in china are subject to a corporate income tax rate of 25% on its taxable income.

No provision for U.S. income taxes is made as the Company has no taxable income in the U.S. In accordance with the relevant tax laws in the British Virgin Islands, Kiwa BVI, as an International Business Company, is exempt from income taxes.

KIWA BIO-TECH PRODUCTS GROUP CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Nine months ended September 30,
	2016			2015
Pre-tax income (loss)	$	410,652		$	(480,051	)

U.S. federal corporate income tax rate		34	%		34	%
Income tax computed at U.S. federal corporate income tax rate		139,622			(163,217	)
Reconciling items:
Rate differential for PRC earnings		(14,043)			17,465
Change of valuation allowance		220,518			115,152
Non-deductible expenses (Non-taxable income)		(267,152	)		30,600
Effective tax expense	$	78,945		$	-

The provisions for income taxes are summarized as follows:

	Nine months ended September 30,
	2016		2015
Current	$	78,945	$	-
Deferred		-		-
Total	$	78,945	$	-

The Company had deferred tax assets as follows:

	September 30, 2016			December 31, 2015
Net operating losses carried forward	$	3,511,402		$	3,398,402
Less: Valuation allowance		(3,511,402	)		(3,398,402	)
Net deferred tax assets	$	-		$	-

The net operating losses carried forward were approximately $8.66 million at September 30, 2016, which will expire between 2016 and 2026. Full valuation allowance has been made because it is considered more likely than not that the deferred tax assets will not be realized through sufficient future earnings of the entity to which the operating losses relate.

14. Subsequent Event

The Company has evaluated subsequent events through the date that these financial statements were issued and determined that there were no subsequent events to disclose in these financial statements.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

This Quarterly Report on Form 10-Q for the three months ended September 30, 2016 contains “forward-looking statements” within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates,” or similar expressions. These forward-looking statements include, among others, statements concerning our expectations regarding our working capital requirements, financing requirements, business, growth prospects, competition and results of operations, and other statements of expectations, beliefs, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. The forward-looking statements in this Quarterly Report on Form 10-Q for the three months ended September 30, 2016 involve known and unknown risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from those expressed in or implied by the forward-looking statements contained herein.

Overview

The Company took its present corporate form in March 2004 when shareholders of Kiwa Bio-Tech Products Group Ltd. (“Kiwa BVI”), a company originally organized under the laws of the British Virgin Islands on June 5, 2002 and Tintic Gold Mining Company (“Tintic”), a corporation originally incorporated in the state of Utah on June 14, 1933 to perform mining operations in Utah, entered into a share exchange transaction. The share exchange transaction left the shareholders of Kiwa BVI owning a majority of Tintic and Kiwa BVI a wholly-owned subsidiary of Tintic. For accounting purposes this transaction was treated as an acquisition of Tintic by Kiwa BVI in the form of a reverse triangular merger and a recapitalization of Kiwa BVI and its wholly owned subsidiary, Kiwa Bio-Tech Products (Shandong) Co., Ltd. (“Kiwa Shandong”). On July 21, 2004, we completed our reincorporation in the State of Delaware.

We have established a subsidiary in China, Kiwa Shandong in 2002, a wholly-owned subsidiary, engaging in the bio-fertilizer business. Formerly, our subsidiary Tianjin Kiwa Feed Co., Ltd. (“Kiwa Tianjin”), was engaged in the bio-enhanced feed business. At the end of 2009, Kiwa Tianjin could no longer use its assets including machinery and inventory in the normal course of operations. The Company has classified the bio-enhanced feed business as discontinued operations. Effective on July 11, 2012, the Company formally dissolved Kiwa Tianjin and Kiwa Shandong is inactive as of September 30, 2016.

On November 30, 2015, we entered into an acquisition agreement (the “Agreement”) with the shareholders of Caber Holdings LTD, whose Chinese name is Hong Kong Baina Group Co., Ltd, located in Hong Kong (“Baina Hong Kong”), and Oriental Baina Co. Ltd. (hereinafter referred to as “Baina Beijing”), Baina Hong Kong’s wholly-owned subsidiary in Beijing, China. Kiwa will rename Baina Beijing to Kiwa Baiao Co. Ltd. Kiwa Baiao Co. Ltd will replace Kiwa’s current subsidiary in China - Kiwa Bio-Tech (Shandong) Co., Ltd (“Kiwa Shandong”) - to operate Kiwa’s bio-fertilizer market expansion and become Kiwa’s platform for future acquisitions of new agricultural-related projects in China. In accordance with the terms of the Agreement, Kiwa agreed to pay US$30,000 to the Baina Hong Kong Shareholders for the acquisition of 100% of the equity of Baina Hong Kong. The acquisition was completed on January 7, 2016. Both Baina Hong Kong and Baina Beijing had no activities before the acquisition date and had no assets and liabilities. The purpose of this acquisition was to acquire Baina Hong Kong’s corporate registration in Hong Kong and in China. The total payment of approximately $34,000 was recorded as intangible assets.

We started to generate some revenues in the nine months ended September 30, 2016 compare with no revenues in the nine months ended September 30, 2015. We incurred a net income of $331,707 and a net loss $480,051 for the nine months ended September 30, 2016 and 2015, respectively.

The Company entered into an agreement with a company, Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (“Gerui”), to allow Gerui sell products with the Company’s trademark. Gerui will pay 10% of total sales amount to the Company as license fee. The Company recognized license fees when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, and no other significant obligations of the Company exist and collectability is reasonably assured.

The Company also entered into agreement with a company, Qingzhou Agricultural Supply Company (“Qingzhou”), on August 1, 2016, to sell 6500 tons of products before December 31, 2016. As of September 28, 2016, the Company has shipped out all the products and recognized revenue of $1,185,309 during the third quarter of this year.

As of September 30, 2016, the Company had cash of $545. Due to shortage of working capital, we have relied on the proceeds from advances from related parties to provide the necessary to fund the development of our business plan and operations. During the nine months ended September 30, 2016, net amount advanced by related parties was $51,500. These funds are insufficient to execute our business plan as currently contemplated. Management is currently looking for alternative sources of capital to fund our operations.

Going Concern

Our consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not purport to represent the realizable or settlement values.

As of September 30, 2016 we had an accumulated deficit of $19,993,105 and a stockholders’ deficiency of $5,024,944. We currently have negative working capital. We will require additional capital to fund our operations.

As of September 30, 2016, our current liabilities were $8,042,656 which exceeded current assets by $3,442,227, representing a current ratio of 0.572; comparably, as of December 31, 2015, we had total current assets of $48,174 and current liabilities of $9,378,304, denoting a current ratio of 0.0051. If we can achieve the necessary financing to increase our working capital, we believe the Company will be well-positioned to generate sales of our products and to generate more revenues in the future. There can be no assurances that we will be successful in obtaining this financing or in increasing our sales revenue if we do obtain the enough financing.

Our independent auditors have added an explanatory paragraph to their audit opinion issued in connection with our financial statements for the latest eight years, which states that the financial statements raise substantial doubt as to our ability to continue as a going concern. Our ability to make operations profitable or obtain additional funding will determine our ability to continue as a going concern.

Trends and Uncertainties in Regulation and Government Policy in China

Foreign Investment Policy Change in China

On March 16, 2007, China’s parliament, the National People’s Congress, adopted the Enterprise Income Tax Law, which took effect on January 1, 2008. The new income tax law sets a unified income tax rate for domestic and foreign companies at 25% and abolishes the favorable policy for foreign invested enterprises. As a result subsidiaries established in China in the future will not enjoy the original favorable policy unless they are certified as qualified high and new technology enterprises.

According to the enterprise income tax law previously in effect, our PRC subsidiaries, Kiwa Shandong and Kiwa Tianjin, were exempt from corporate income taxes for their first two profitable years and were entitled to a 50% tax reduction for the succeeding three years. Now that the new income tax law is in effect, fiscal year 2008 is regarded as the first profitable year even if Kiwa Shandong or Kiwa Tianjin were not profitable that year; thereby narrowing the time period when the favorable tax treatment may be available to us.

Results of Operations

Results of Operations for Three Months Ended September 30, 2016 and 2015

Revenue

Revenue was $1,261,544 and nil for the three months ended September 30, 2016 and 2015, respectively. Revenue was generated from licensing our trademark to Gerui of $76,235 and sales of products of $1,185,309. We signed the license agreement with Gerui to allow Gerui to sell fertilizer using our trademark in December 2015 and the sales agreement with Qingzhou to sell fertilizer products in August 2016.

Cost of Revenue and Gross Profit

Cost of revenue for the three months ended September 30, 2016 was $770,451, reflecting an increase of 100% from the same period last year. Consequently, gross profit margin as a percentage of total sales is 38.93% compared with nil for the same period last year, principally due to the increase of sales to Qingzhou.

General and Administration

General and administration expenses for the three months ended September 30, 2016 and 2015 were $196,019 and $72,968, respectively, representing a $123,051 or 168.64% increase due to the operations started in 2016. General and administrative expenses include salaries, travel and entertainment, rent, office expense, telephone expense, consulting expense and insurance costs etc.

Research and Development

Research and development expense for the three months ended September 30, 2016 reflected an increase of $34,923 or 87.61% from $39,860 in the three months ended September 30, 2015 to $74,783 for the same period of 2016. In July 2006, the Company opened a new research center with CAU through our subsidiary, Kiwa Shandong, which goes under the name, KiwaCAU BioTech Research & Development Center. Pursuant to an agreement reached between CAU and Kiwa Shandong on November 14, 2006, Kiwa Shandong agreed to contribute RMB 1 million (approximately $160,000) each year to fund research at the R&D Center. The term of the agreement is ten years.

The Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”) on November 5, 2015. Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.

Penalty Expense

The Company incurred liquidated damages resulting from the default of 6% Notes. The penalty charge, which is calculated monthly at 2% of the outstanding amounts of convertible notes and unpaid interest on the notes, was $19,564 and $18,208 for three months ended September 30, 2016 and 2015, respectively. The increase of penalty expense was mainly due to accrued and unpaid interest on the notes.

Interest Expenses

Net interest expense was $28,181 for the three months ended September 30, 2016 and $28,189 for the same period of 2015.

Net Income / Loss

During the three months ended September 30, 2016, net income was $93,601 and for the same period of 2015 net loss was $159,225, representing a change of $252,826 or 158.79%. The change was due to the reasons discussed above.

Comprehensive Income/Loss

Comprehensive income for the three months ended September 30, 2016 was $103,366. Comparably, during the same period of 2015, comprehensive income was $168,247. The change was due to the reasons discussed above.

Results of Operations for Nine Months Ended September 30, 2016 and 2015

Revenue

Revenue was $1,971,639 and nil for the nine months ended September 30, 2016 and 2015, respectively. Revenue was generated from licensing our trademark to Gerui of $786,330 and sales of products of $1,185,309. We signed the license agreement with Gerui to allow Gerui to sell fertilizer using our trademark in December 2015 and the sales agreement with Qingzhou to sell fertilizer products in August 2016.

Cost of Revenue and Gross Profit

Cost of revenue for the nine months ended September 30, 2016 was $770,451, reflecting an increase of 100% from the same period last year. Consequently, gross profit margin as a percentage of total sales is 60.92% compared with nil for the same period last year, principally due to the increase of sales to Qingzhou.

General and Administration

General and administration expenses for nine months ended September 30, 2016 and 2015 were $421,688 and $220,510, respectively, representing a $201,178 or 91.2% increase due to the operations started in 2016. General and administrative expenses include salaries, travel and entertainment, rent, office expense, telephone expense, consulting expense and insurance costs etc.

Research and Development

Research and development expense for the nine months ended September 30, 2016 reflected an increase of $105,065 or 86.5% from $121,487 in the nine months ended September 30, 2015 to $226,552 for the same period of 2016. In July 2006, the Company opened a new research center with CAU through our subsidiary, Kiwa Shandong, which goes under the name, Kiwa-CAU Bio-Tech Research & Development Center. Pursuant to an agreement reached between CAU and Kiwa Shandong on November 14, 2006, Kiwa Shandong agreed to contribute RMB 1 million (approximately $160,000) each year to fund research at the R&D Center. The term of the agreement is ten years.

Penalty Expense

The Company incurred liquidated damages resulting from the default of 6% Notes. The penalty charge, which is calculated monthly at 2% of the outstanding amounts of convertible notes and unpaid interest on the notes, was $57,672 and $53,605 for the nine months ended September 30, 2016 and 2015, respectively. The increase of penalty expense was mainly due to accrued and unpaid interest on the notes.

Interest Expenses

Net interest expense was $84,624 for the nine months ended September 30, 2016 and $84,449 for the same period of 2015.

Net Income / Loss

During the nine months ended September 30, 2016, net income was $331,707, and for the same period of 2015 net loss was $480,051, representing a change of $811,758 or 169.1%. The change was due to the reasons discussed above.

Comprehensive Income/Loss

Comprehensive income for the nine months ended September 30, 2016 was $435,577. Comparably, during the same period of 2015, comprehensive loss was $201,485. The change was due to the reasons discussed above.

Liquidity and Capital Resources

Since inception of our ag-biotech business in 2002, we have relied on the proceeds from the sale of our equity securities and loans from both unrelated and related parties to provide the resources necessary to fund our operations and the execution of our business plan. During the nine months ended September 30, 2016, the advances from related parties, net of repayment by the Company to related parties, was $51,500. As of September 30, 2016, our current liabilities exceeded current assets by $3,442,227, representing a current ratio of 0.572. Comparably, as of December 31, 2015, our current liabilities exceeded current assets by $9,330,130, denoting a current ratio of 0.005.

As of September 30, 2016 and December 31, 2015, we had cash of $545 and $721, respectively. Changes in cash balances are outlined as follows:

During the nine months ended September 30, 2016, our operations used cash of $737,758 as compared with $77,853 used in the same period of 2015. Cash was mainly used for working capital for public company operation.

During the nine months ended September 30, 2016 and 2015, we used $79,604 and nil cash for investing activities.

During the first three quarters of 2016, our financing activities incurred net cash inflow of $817,781, $51,500 of which are generated from advances from related parties, net of repayment to related parties and $766,281 of which are generated from sales of common stock to stockholders. During the nine months ended September 30, 2015, we generated $77,988 from financing activities due to proceeds received from related party loans.

Given the facts that:

Outstanding note payable of $360,000 as of September 30, 2016. This note has been in default since July 2007.

To the extent that we are unable to successfully raise capital necessary to fund our future cash requirements on a timely basis and under acceptable terms and conditions, we will not have sufficient cash resources to maintain operations, and may have to curtail operations and consider a formal or informal restructuring or reorganization.

Commitments and Contingencies

See Note 12 to the Consolidated Financial Statements under Item 1 in Part I.

Off-Balance Sheet Arrangements

At September 30, 2016, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 4. CONTROLS AND PROCEDURES

(a) Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined in Securities Exchange Act Rule 13a-15(e)) as of the end of the quarterly period covered by this report, have concluded that our disclosure controls and procedures are not effective to reasonably ensure that material information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s Rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The principal basis for this conclusion is the lack of segregation of duties within our financial function and the lack of an operating Audit Committee.

(b) Changes in Internal Control over Financial Reporting

There have not been any changes in the Company's internal control over financial reporting (as such term is defined in Rules 13a-15(f) under the Exchange Act) during the fiscal period to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

None.

ITEM 1A. RISK FACTORS

Smaller reporting companies are not required to provide the information required by this item.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On March 24, 2016, (1) the Company issued 2,900,000 shares of common stock to Mr. Wei Li in exchange for the cancellation of approximately $2,900,000 of debt: (2) the Company issued 240,000 shares of common stock to Yvonne Wang in exchange for the cancellation of $240,000 of debt; (3) on March 24, 2016, the Company issued 1,000 shares of common stock to Mark E. Crone in payment of amounts due to Mr. Crone for legal services; (4) On April 17, 2016, the Company issued 125,000 shares of common stock to Minqing Zeng in lieu of an investment of $100,000 ($0.80 per share); (5) On May 9, 2016, the Company issued 50,000 shares of common stock to Tzu-Yun Cheng in lieu of an investment of $40,000 ($0.80 per share); (6) On May 9, 2016, the Company issued 45,000 shares of common stock to Zhiming Zhu in lieu of an investment of $36,000 ($0.80 per share); (7) On July 20, 2016, the Company issued 20,000 shares of common stock to Hang Zhao in lieu of an investment of $16,000 ($0.80 per share); (8) On July 20, 2016, the Company issued 10,000 shares of common stock to Shiwei Xie in lieu of an investment of $8,000 ($0.80 per share); (9) On July 20, 2016, the Company issued 30,000 shares of common stock to Xiaoqiang Yu in lieu of an investment of $24,000 ($0.80 per share); (10) On July 21, 2016, the Company issued 20,000 shares of common stock to Hang Zhao in lieu of an investment of $16,000 ($0.80 per share); (11) On July 22, 2016, the Company issued 10,000 shares of common stock to Xiaoqiang Yu in lieu of an investment of $8,000 ($0.80 per share); (12) On July 29, 2016, the Company issued 40,000 shares of common stock to Xiangrong Chen in lieu of an investment of $32,000 ($0.80 per share); (13) On August 11, 2016, the Company issued 101,947 shares of common stock to Jimmy Zhou in lieu of salary payable settlement of $50,974 ($0.50 per share); (14) On August 23, 2016, the Company issued 150,000 shares of common stock to Bing Zhang in lieu of an investment of $120,000 ($0.80 per share); (15) On September 12, 2016, the Company issued 750,000 shares of common stock to Lifeng Liu, Zhenping Li and Qi Jiang in lieu of an investment of $600,000 ($0.80 per share); (16) On September 21, 2016, the Company issued 150,000 shares of common stock to Demei Yang in lieu of an investment of $120,000 ($0.80 per share); (17) On September 22, 2016, the Company issued 150,000 shares of common stock to Weihong Shan in lieu of an investment of $120,000 ($0.80 per share); (18) On September 28, 2016, the Company issued 100,000 shares of common stock to Lei Hou in lieu of an investment of $80,000 ($0.80 per share); (19) On August 29, 2016, the Company issued 60,000 shares of common stock to Qingke Xing in lieu of M&A and financing in China consulting service of $51,000 ($0.85 per share); (20) On August 31, 2016, the Company issued 1,530,808 shares of common stock to Equities.com Inc., Geng Liu, Lixin Tian and Xu Liu in lieu of Investor Relation and growth and development strategy consulting service of $1,515,500 ($0.99 per share); (21) On September 6, 2016, the Company issued 20,000 shares of common stock to Growth Circle Inc. in lieu of investor relation consulting service of $19,800 ($0.99 per share); (22) On September 15, 2016, the Company issued 100,000 shares of common stock to WSMG Advisor Inc. in lieu of investor relation consulting service of $102,000 ($1.02 per share).

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine safety disclosures

Not applicable.

Item 5. Other Information

None.

Item 6. Exhibits

Exhibit No.		Description

31.1/31.2		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) and Rule15d-14(a) of the Securities Exchange Act of 1934, as amended

32.1/32.2		Certification of Principal Executive Officer and Principal Financial Officer, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	KIWA BIO-TECH PRODUCTS GROUP CORPORATION

November 21, 2016	By:	/s/ Yvonne Wang
		Yvonne Wang, Interim Chief Executive Officer and Interim Chief Financial Officer

EX-31.1 2 ex31-1.htm

EXHIBIT 31.1

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, Yvonne Wang, certify that:

	1.	I have reviewed this Form 10-Q for the period ended September 30, 2016 of Kiwa Bio-Tech Products Group Corporation;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 21, 2016

/s/ Yvonne Wang
Yvonne Wang
Principal Executive Officer

EX-31.2 3 ex31-2.htm

EXHIBIT 31.2

CERTIFICATION PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

I, Yvonne Wang, certify that:

	1.	I have reviewed this Form 10-Q for the period ended September 30, 2016 of Kiwa Bio-Tech Products Group Corporation;

	2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

	3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

	4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: November 21, 2016

/s/ Yvonne Wang
Yvonne Wang
Principal Financial Officer

EX-32.1 4 ex32-1.htm

EXHIBIT 32.1

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Kiwa Bio-Tech Products Group Corporation, a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The quarterly report on Form 10-Q for the period ended September 30, 2016 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: November 21, 2016

	/s/ Yvonne Wang
	Yvonne Wang
	Principal Executive Officer

A signed original of this written statement required by Section 906 has been provided to KIWA BIO-TECH PRODUCTS GROUP CORPORATION and will be retained by KIWA BIO-TECH PRODUCTS GROUP CORPORATION and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2 5 ex32-2.htm

EXHIBIT 32.2

CERTIFICATIONS PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

Date: November 21, 2016

	/s/ Yvonne Wang
	Yvonne Wang
	Principal Financial and Accounting Officer

EX-101.INS 6 kwbt-20160930.xml XBRL INSTANCE FILE 0001159275 2016-01-01 2016-09-30 0001159275 2016-09-30 0001159275 2015-12-31 0001159275 2015-01-01 2015-09-30 0001159275 KWBT:BalanceSheetItemsExceptForEquityAccountsMember currency:CNY 2016-09-30 0001159275 KWBT:ItemsInStatementsOfIncomeAndCashFlowsMember currency:CNY 2016-09-30 0001159275 KWBT:BalanceSheetItemsExceptForEquityAccountsMember currency:CNY 2015-12-31 0001159275 KWBT:ItemsInStatementsOfIncomeAndCashFlowsMember currency:CNY 2015-09-30 0001159275 us-gaap:ChiefExecutiveOfficerMember KWBT:NonTradeTransactionMember 2016-09-30 0001159275 us-gaap:ChiefExecutiveOfficerMember KWBT:NonTradeTransactionMember 2015-12-31 0001159275 KWBT:KangtaiMember KWBT:NonTradeTransactionMember 2016-09-30 0001159275 KWBT:KangtaiMember KWBT:NonTradeTransactionMember 2015-12-31 0001159275 KWBT:KiwaCauRAndDCenterMember KWBT:TradeTransactionMember 2016-09-30 0001159275 KWBT:KiwaCauRAndDCenterMember KWBT:TradeTransactionMember 2015-12-31 0001159275 KWBT:SecretaryMember KWBT:NonTradeTransactionMember 2016-09-30 0001159275 KWBT:SecretaryMember KWBT:NonTradeTransactionMember 2015-12-31 0001159275 KWBT:KiwaCauRAndDCenterMember 2016-01-01 2016-09-30 0001159275 KWBT:KiwaCauRAndDCenterMember currency:CNY 2006-11-13 2006-11-14 0001159275 KWBT:StockIncentivePlan2004Member 2006-12-11 2006-12-12 0001159275 KWBT:ZouchengShandongProvinceMember 2016-09-30 0001159275 KWBT:ZouchengShandongProvinceMember us-gaap:MinimumMember 2016-09-30 0001159275 KWBT:ZouchengShandongProvinceMember us-gaap:MaximumMember 2016-09-30 0001159275 2016-11-18 0001159275 us-gaap:ChiefExecutiveOfficerMember 2016-09-30 0001159275 KWBT:MsYvonneWangMember 2015-12-31 0001159275 us-gaap:ChiefExecutiveOfficerMember KWBT:KangtaiInternationalLogisticsBeijingCoLtdMember 2016-09-30 0001159275 us-gaap:ChiefExecutiveOfficerMember KWBT:KangtaiInternationalLogisticsBeijingCoLtdMember 2015-12-31 0001159275 KWBT:KiwaCauRAndDCenterMember currency:CNY 2016-01-01 2016-09-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember currency:CNY 2016-01-01 2016-09-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember 2016-01-01 2016-09-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember KWBT:TradeTransactionMember 2016-09-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember KWBT:TradeTransactionMember 2015-12-31 0001159275 KWBT:TwoInstitutesInChinaMember currency:CNY 2015-11-04 2015-11-05 0001159275 KWBT:NoteSixPercentageMember us-gaap:IntellectualPropertyMember 2016-01-01 2016-09-30 0001159275 KWBT:UnrelatedIndividualMember 2007-05-29 0001159275 KWBT:UnrelatedIndividualMember 2007-05-28 2007-05-29 0001159275 KWBT:InvestlinkChinaLimitedMember 2007-05-28 2007-05-29 0001159275 2016-01-13 2016-01-14 0001159275 2016-01-14 0001159275 KWBT:FirsTrustGroupIncMember KWBT:NoteSixPercentageMember 2006-06-28 2006-06-29 0001159275 KWBT:FirsTrustGroupIncMember KWBT:NoteSixPercentageMember 2006-06-29 0001159275 KWBT:NoteSixPercentageMember us-gaap:IntellectualPropertyMember 2016-09-30 0001159275 2014-12-31 0001159275 2015-09-30 0001159275 KWBT:KangtanGeruiMember 2016-01-01 2016-09-30 0001159275 us-gaap:ChiefExecutiveOfficerMember 2016-01-01 2016-09-30 0001159275 KWBT:MsYvonneWangMember 2016-01-01 2016-09-30 0001159275 KWBT:KiwaCauRAndDCenterMember 2015-12-31 0001159275 KWBT:KiwaCauRAndDCenterMember 2016-09-30 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember 2015-12-31 0001159275 KWBT:CAASIARRPAndIAEDInstitutesMember 2016-09-30 0001159275 KWBT:MrLiMember 2016-01-01 2016-09-30 0001159275 KWBT:WangMember 2016-01-01 2016-09-30 0001159275 us-gaap:ChiefExecutiveOfficerMember 2015-01-01 2015-12-31 0001159275 KWBT:FirsTrustGroupIncMember 2016-01-01 2016-09-30 0001159275 KWBT:FirsTrustGroupIncMember 2015-01-01 2015-09-30 0001159275 KWBT:BainaHongKongShareholdersMember 2015-11-30 0001159275 KWBT:BainaHongKongShareholdersMember 2015-11-01 2015-11-30 0001159275 2016-07-01 2016-09-30 0001159275 2015-07-01 2015-09-30 0001159275 KWBT:SixteenShareholdersMember 2016-01-01 2016-09-30 0001159275 KWBT:NonRelatedPartiesMember 2016-09-30 0001159275 KWBT:MsYvonneWangMember 2016-03-23 2016-03-24 0001159275 KWBT:SixteenShareholdersMember 2016-09-30 0001159275 KWBT:JimmyZhouMember 2016-08-01 2016-08-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CNY KIWA BIO-TECH PRODUCTS GROUP CORP 10-Q 2016-09-30 false --12-31 Smaller Reporting Company KWBT

545

721

2963

3080

331707

-480051

93601

-159225

6.6714

6.5806

6.4857

6.1735

2879307

-12173

1206644

1125553

130845

18425

10710

299064

1445199

4310176

160000

1000000

160000

1000000

0.06

0.18

0.06

P3M

2000000

18000000 24000000

3511402

3398402

3511402

3398402

0.34

1723776

1773131

0.001

100000000

8603981

2000000

8603981

2000000

0.001

20000000

500000

142296

138054

47745

46397

410652

-480051

172546

-159225

435577

-201485

103366

168247

13039

3293

-57672 -53605

51500

77988

817781

77988

-595

-18

-176

117

6. Related Party Transactions and Balances   Amounts due to related parties consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Item</td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nature</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Notes</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 115%">Mr. Wei Li (“Mr. Li”)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 8%; text-align: center; line-height: 115%">Non-trade</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 5%; text-align: center; line-height: 115%">(1)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> $</td> <td style="width: 15%; text-align: right; line-height: 115%">2,879,307</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. (“Kangtai”)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Non-trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(2)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(12,173</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Ms. Yvonne Wang (“Ms. Wang”)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Non-trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(3)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">107,710</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">299,064</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Subtotal</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">107,710</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,166,198</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Kiwa-CAU R&D Center</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(4)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,206,644</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,125,553</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">CAAS IARRP and IAED Institutes</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(5)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">130,845</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">18,425</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Subtotal</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">1,337,489</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">1,143,978</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,445,199</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">4,310,176</td> <td style="line-height: 115%"> </td></tr> </table>   (1)       Mr. Li   Mr. Li was the Chairman of the Board until November 20, 2015 and was the Chief Executive Officer of the Company until July 1, 2015.   Advances and Loans   As of December 31, 2015, the remaining balance due Mr. Li was 2,879,307. During the nine months ended September 30, 2016, Mr. Li received 2,900,000 shares of common stock in lieu of the cancellation and repayment of an aggregate of $2,879,307 and salary payable.   Guarantees for the Company   Mr. Li has pledged without any compensation from the Company, all of his common stock of the Company as collateral security for the Company’s obligations under the 6% Notes. (See Note 8 below).   (2)       Kangtai   Kangtai, formerly named Kangtai International Logistics (Beijing) Co., Ltd., Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd., is a private company, 28% owned by Mr. Li. Mr. Li is the Chairman of Kangtai.   On December 31, 2015, the amount due from Kangtai was $12,173. The balance due from Kangtai on September 30, 2016 was nil.   (3)       Ms. Wang   Ms. Wang is the Secretary of the Company until November 20, 2015. Effective as of November 20, 2015, the Company appointed Ms. Wang as the Chairman of the Board. Effective as of December 15, 2015, the Company appointed Ms. Wang as the Company’s Chief Operating Officer.   On December 31, 2015, the amount due to Ms. Wang was $299,064. On March 24, 2016, the Company issued 240,000 shares of common stock to Ms. Wang to pay off the loan balance of $240,000. During the nine months ended September 30, 2016, Ms. Wang paid various expenses on behalf of the Company. As of September 30, 2016, the amount due to Ms. Wang was $107,710.   (4) Kiwa-CAU R&D Center   Pursuant to the agreement with China Agricultural University (“CAU”), the Company agree to invest RMB 1 million (approximately $160,000) each year to fund research at Kiwa-CAU R&D Center. Prof. Qi Wang, one of the Company’s directors, is also the director of Kiwa-CAU R&D Center.   On December 31, 2015, the amount due to Kiwa-CAU R&D Center was $1,125,553. As of September 30, 2016, the outstanding balance due to Kiwa-CAU R&D Center was $1,206,644.   (5) CAAS IARRP and IAED Institutes   On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.   On December 31, 2015, the amount due to Kiwa- CAAS IARRP and IAED Institutes R&D Center was $18,425. As of September 30, 2016, the outstanding balance due to Kiwa-CAAS IARRP and IAED Institutes R&D center was $130,845.

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; padding-left: 8.7pt; text-align: center; line-height: 115%; text-indent: -8.7pt">As of September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">As of December 31, 2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify; line-height: 115%">Balance sheet items, except for equity accounts</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.6714</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.4857</td> <td style="width: 1%; line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nine months ended September 30,</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify; line-height: 115%">Items in the statements of income and cash flows</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.5806</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.1735</td> <td style="width: 1%; line-height: 115%"> </td></tr> </table>

Amounts due to related parties consisted of the following:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Item</td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nature</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Notes</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 44%; line-height: 115%">Mr. Wei Li (“Mr. Li”)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 8%; text-align: center; line-height: 115%">Non-trade</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 5%; text-align: center; line-height: 115%">(1)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> $</td> <td style="width: 15%; text-align: right; line-height: 115%">2,879,307</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. (“Kangtai”)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Non-trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(2)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(12,173</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Ms. Yvonne Wang (“Ms. Wang”)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Non-trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(3)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">107,710</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">299,064</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Subtotal</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">107,710</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">3,166,198</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Kiwa-CAU R&D Center</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(4)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,206,644</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,125,553</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">CAAS IARRP and IAED Institutes</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">Trade</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">(5)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">130,845</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">18,425</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Subtotal</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">1,337,489</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">1,143,978</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,445,199</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">4,310,176</td> <td style="line-height: 115%"> </td></tr> </table>   (1)       Mr. Li   Mr. Li was the Chairman of the Board until November 20, 2015 and was the Chief Executive Officer of the Company until July 1, 2015.   Advances and Loans   As of December 31, 2015, the remaining balance due Mr. Li was 2,879,307. During the nine months ended September 30, 2016, Mr. Li received 2,900,000 shares of common stock in lieu of the cancellation and repayment of an aggregate of $2,879,307 and salary payable.   Guarantees for the Company   Mr. Li has pledged without any compensation from the Company, all of his common stock of the Company as collateral security for the Company’s obligations under the 6% Notes. (See Note 8 below).   (2)       Kangtai   Kangtai, formerly named Kangtai International Logistics (Beijing) Co., Ltd., Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd., is a private company, 28% owned by Mr. Li. Mr. Li is the Chairman of Kangtai.   On December 31, 2015, the amount due from Kangtai was $12,173. The balance due from Kangtai on September 30, 2016 was nil.   (3)       Ms. Wang   Ms. Wang is the Secretary of the Company until November 20, 2015. Effective as of November 20, 2015, the Company appointed Ms. Wang as the Chairman of the Board. Effective as of December 15, 2015, the Company appointed Ms. Wang as the Company’s Chief Operating Officer.   On December 31, 2015, the amount due to Ms. Wang was $299,064. On March 24, 2016, the Company issued 240,000 shares of common stock to Ms. Wang to pay off the loan balance of $240,000. During the nine months ended September 30, 2016, Ms. Wang paid various expenses on behalf of the Company. As of September 30, 2016, the amount due to Ms. Wang was $107,710.   (4) Kiwa-CAU R&D Center   Pursuant to the agreement with China Agricultural University (“CAU”), the Company agree to invest RMB 1 million (approximately $160,000) each year to fund research at Kiwa-CAU R&D Center. Prof. Qi Wang, one of the Company’s directors, is also the director of Kiwa-CAU R&D Center.   On December 31, 2015, the amount due to Kiwa-CAU R&D Center was $1,125,553. As of September 30, 2016, the outstanding balance due to Kiwa-CAU R&D Center was $1,206,644.   (5) CAAS IARRP and IAED Institutes   On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof. Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.

Summary of options issued and outstanding at September 30, 2016 and the movements during the nine months then ended are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of underlying shares</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted- Average Exercise Price Per Share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Aggregate Intrinsic Value (1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted- Average Contractual Life Remaining in Years</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; line-height: 115%">Outstanding at December 31, 2015</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 9%; text-align: right; line-height: 115%">6,163</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">35</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 10%; text-align: right; line-height: 115%">1</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Expired</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Outstanding at September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">6,163</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">35</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Exercisable at September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,163</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">35</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">(1) </td> <td style="text-align: justify; line-height: 115%">The market value of the Company’s common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.</td></tr> </table>

The Company had deferred tax assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 115%">Net operating losses carried forward</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">3,511,402</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">3,398,402</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Less: Valuation allowance</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(3,511,402</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(3,398,402</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Net deferred tax assets</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>

8603981

299064

1125553

18425

-12173

P1Y

P3M

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> Nine months ended September 30,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 115%">Pre-tax income (loss)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">410,652</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(480,051</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">U.S. federal corporate income tax rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34</td> <td style="line-height: 115%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Income tax computed at U.S. federal corporate income tax rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">139,622</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(163,217</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Reconciling items:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Rate differential for PRC earnings</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(14,043)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">17,465</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Change of valuation allowance</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">220,518</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">115,152</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Non-deductible expenses (Non-taxable income)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(267,152</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,600</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Effective tax expense</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">78,945</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>

0.28

The term of this Agreement is ten years starting from July 1, 2006.

0.25

6163

8042656

9378304

1014480

930062

9766432

11151435

-5024944

-11100454

-19993105

-20324812

500000

3442227

8660000

2007-07-27

2009-06-29

360000

6178336

3140000

2879307

240000

93993

110604

123604

47604

226392

121487

-737758

-77853

-84418

-84357

477284

-18752

0.25

30892

1-for-200

120000000

16919

16857

0.06

0.15

0.06

0.40 0.0499

120000

0.02 1.10

592901

179897

0001159275 Q3

4741488

50981

34000

69652

2807

4600429

48174

1224410

479659

462423 404752

586958

478209

1675900

1632881

150250

107710 3166198 1337489 1143978

266103

273722

13415

13800

1076266

300247

1723776

1773131

4741488

50981

-165109

-268979

15684507

9490837

500

8604

2000

1971639

1261544

552948

-341997

220291

-112828

648240

341997

270802

112828

226552

121487

74783

39860

421688

220510

196019

72968

-84624

-84449

-28181

-28189

-57672 -53605 -19564 -18208

103870

278566

9765

327472

0.04

-0.24

0.01

-0.08

0.07

-0.24

0.01

-0.08

1240550

545

0.10

2879307

240000

3141000

107710

1206644

130845

3141000

50974

expire between 2016 and 2026.

139622

-163217

78945

-267152

30600

220518

115152

-14043

17465

3141000

1650000

101947

57672 53605

67500

30000

1.00

794868

79604

-79604

766281

1320000

479659

2900000

1.43

1639583

58432

47453

34112

560341

770451

1201188

491093

4617535

2000000

6300700

2000000

7769954

2000000

7064969

2000000

7500

-1700605

11988

37809

50974 1630583 34112 101947 101947 1710808 1710808

0.8

78945

2016 1677459

37295

512003

524205

1710808

-57717

57717

1688300

1. Description of Business and Organization   References herein to Kiwa or the Company refer to Kiwa Bio-Tech Products Group Corporation and its wholly-owned subsidiaries unless the context specifically states or implies otherwise.   Business The Companys business is to develop, manufacture, distribute and market innovative, cost-effective and environmentally safe bio-technological products for agriculture markets located primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.   Acquisition of Caber Holdings Ltd - On November 30, 2015, we entered into an acquisition agreement (the Agreement) with the shareholders of Caber Holdings LTD, whose Chinese name is Hong Kong Baina Group Co., Ltd, located in Hong Kong (Baina Hong Kong), and Oriental Baina Co. Ltd. (hereinafter referred to as Baina Beijing), Baina Hong Kongs wholly-owned subsidiary in Beijing, China. Kiwa will rename Baina Beijing to Kiwa Baiao Co. Ltd. Kiwa Baiao Co. Ltd will replace Kiwas current subsidiary in China - Kiwa Bio-Tech (Shandong) Co., Ltd (Kiwa Shandong) - to operate Kiwas bio-fertilizer market expansion and become Kiwas platform for future acquisitions of new agricultural-related projects in China. In accordance with the terms of the Agreement, Kiwa agreed to pay US$30,000 to the Baina Hong Kong Shareholders for the acquisition of 100% of the equity of Baina Hong Kong. The acquisition was completed on January 7, 2016. Both Baina Hong Kong and Baina Beijing had no activities before the acquisition date and had no assets and liabilities. The purpose of this acquisition was to acquire Baina Hong Kongs corporate registration in Hong Kong and in China. The total payment of approximately $34,000 was recorded as intangible assets.   Restatement - Based on the previously restated consolidated financial statements for the year ended December 31, 2014 which were filed with companys annual report Form 10K for the year ended December 31, 2015, the management of the Company has concluded that consolidated statement of comprehensive income (loss) for the three and nine months ended September 30, 2015 should be restated to record accrued interest expense of $22,500 and $67,500 respectively. (see Note 9)

2. Going Concern   The consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The carrying amounts of assets and liabilities presented in the consolidated financial statements do not purport to represent the realizable or settlement values.   As of September 30, 2016, the Company had cash of $545. The Company had working capital deficit of $3,442,227 and an accumulated deficit of $ 19,993,105 and a stockholders deficiency of $5,024,944 as of September 30, 2016. This trend is expected to continue. These factors, among others, create substantial doubt about the Companys ability to continue as a going concern. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.   The Company plans to (1) raise finance from related-parties, local banks, other financial institutions and other stock market to meet cash demand of daily demand; and (2) raise capital to resume operations. However, there can be no assurance that we will be successful in obtaining this financing (3) The Companys business plan is to develop, manufacture, distribute and market innovative, cost-effective and environmentally safe biotechnological products for agriculture markets located primarily in China. The Company has acquired technologies to produce and market bio-fertilizer.

3. Summaries of Significant Accounting Policies   Principle of consolidation - These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant inter-company balances or transactions are eliminated on consolidation.   Basis of preparation - These interim consolidated financial statements are unaudited. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year or any other periods. The (a) consolidated balance sheet as of December 31, 2015, which was derived from audited financial statements, and (b) the unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Companys Annual Report on Form 10-K for the year ended December 31, 2015.    Reverse Split - On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Companys authorized capital stock was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.   Use of Estimates - The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the bad debt provision, impairment of long-lived assets, depreciation and amortization, valuation allowance of deferred tax assets and fair value of warrants and options.   Foreign Currency Translation - The Company uses United States dollars (US Dollar or US$ or $) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (RMB), being the primary currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of income is translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Companys financial statements are recorded as accumulated other comprehensive income.   The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; padding-left: 8.7pt; text-align: center; text-indent: -8.7pt">As of September 30, 2016</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">As of December 31, 2015</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify">Balance sheet items, except for equity accounts</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">US$1 = RMB 6.6714</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">US$1 = RMB 6.4857</td> <td style="width: 1%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"> </td> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center">Nine months ended September 30,</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">2016</td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center">2015</td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify">Items in the statements of income and cash flows</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">US$1 = RMB 6.5806</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 18%; text-align: center">US$1 = RMB 6.1735</td> <td style="width: 1%"> </td></tr> </table>   Impairment of Long-Lived Assets - We periodically evaluate our investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Our judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, we make assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets. Based on our analysis, no further impairment of long-lived assets was charged during the nine months ended September 30, 2016.   Revenue Recognition - The Companys revenue includes two parts: Part I represents fees per licensing agreement. The Company entered into an agreement with a company, Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (Gerui), to allow Gerui sell products with the Companys trademark. Gerui will pay 10% of total sales amount to the Company as license fee.   Part II represents the revenues from sales of products purchased. The Company recognized license fees and revenue from sales of products when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, and no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as advances from customers.   Accounts Receivables - Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.    Income Taxes - The Company accounts for income taxes under the provisions of FASB ASC Topic 740, Income Tax, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.   Fair value measurements - ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:   Level 1 - Quoted prices in active markets for identical assets or liabilities.   Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.   Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The carrying values of cash and cash equivalents, trade receivables and payables, and short-term debts approximate their fair values due to their short maturities.   There were no assets and liabilities measured at fair value on a nonrecurring basis as of September 30, 2016 and December 31, 2015.

4. Prepaid expenses   The Company issued 1,710,808 shares of common stock to three consulting companies for the investor relation consulting service and four individuals for the growth and development strategy consulting service in China, which represents the amount of $1,688,300 based on quoted price at issuance. The Company amortized the consulting fee over the service periods per agreements. For the nine months ended September 30, 2016, the amortization of consulting expense was $57,717.

5. Advance to customer - Gerui   As of September 30, 2016, Advance to customer-Gerui was $1,677,459, which represents the prepayment to Gerui, the main customer, to subcontract the manufacturing of products to an unrelated company, Shandong Deluke Company.

7. Other Payable   Other payable includes the payables to two potential investors and subscription received in advance. As of September 30, 2016, those two potential investors made the first payments of $479,659 to the Company and the investment agreements haven’t been reached yet. Those two potential investors are non-related parties.

8. Convertible Notes Payable   Convertible notes payable consists of 6% secured convertible notes issued to FirsTrust Group Inc. on June 29, 2006. The notes beard interest at 6% and were due on June 29, 2009. Once the note is pass due, the interest rate increased to 15% per annum. The Company accrued $16,919 and $16,857 interest expense on convertible notes for the nine months ended September 30, 2016 and 2015, respectively.   The conversion price of the 6% Notes is based on a 40% discount to the average of the trading price of the Company’s common stock on the OTC Bulletin Board over a 20-day trading period. The conversion price is also adjusted for certain subsequent issuances of equity securities of the Company at prices below the conversion price then in effect. The 6% Notes contain a volume limitation that prohibits the holder from further converting the 6% Notes if doing so would cause the holder and its affiliates to hold more than 4.99% of the Company’s outstanding common stock. In addition, the holder of the 6% Notes agrees that they may not convert more than their pro-rata share (based on original principal amount) of the greater of $120,000 principal amount of the 6% Notes per calendar month or the average daily dollar volume calculated during the 10 business days prior to a conversion, per conversion. This conversion limit has since been eliminated pursuant to an agreement by the Company and the Purchasers.   The Company incurs a financial penalty in cash or shares at the option of the Company (equal to 2% of the outstanding amount of the Notes per month plus accrued and unpaid interest on the Notes, prorated for partial months) if it breaches this or other affirmative covenants in the Purchase Agreement, including a covenant to maintain a sufficient number of authorized shares under its Certificate of Incorporation to cover at least 110% of the stock issuable upon full conversion of the Notes. Pursuant to the relevant provisions for liquidated damages in the Purchase Agreement, the Company has accrued the penalty of $57,672 and $53,605 for the nine months ended September 30, 2016 and 2015, respectively.   The 6% Notes require the Company to procure the Purchaser’s consent prior to taking certain actions including the payment of dividends, repurchasing stock, incurring debt, guaranteeing obligations, merging or restructuring the Company, or selling significant assets.    The Company’s obligations under the 6% Notes are secured by a first priority security interest in the Company’s intellectual property pursuant to an Intellectual Property Security Agreement with the Purchasers, and by a first priority security interest in all of the Company’s other assets pursuant to a Security Agreement with the Purchasers. In addition, Mr. Li, the Company’s Chief Executive Officer until July 1, 2015, has pledged all of his common stock of the Company as collateral for the Company’s obligations under the 6% Notes. The intellectual property pledged had a cost of $592,901 which carrying value of $179,897 was fully impaired during the year ended December 31, 2009.

9. Note payable   On May 29, 2007, the Company issued a $360,000 promissory note to an unrelated individual. This note bears interest at 18% per annum and was due on July 27, 2007. This note is currently in default and bears interest of 25% per annum (the Default rate) until paid in full. This note is secured by a pledge of 6,178,336 (post-reverse split 30,892) shares of the Companys common stock owned by Investlink (China) Limited, a British Virgin Island corporation. The Company accrued $67,500 and $67,500 interest expense on note payable for the nine months ended September 30, 2016 and 2015, respectively.

10. Stockholders Equity   During the nine months ended September 30, 2016, the Company issued 3,140,000 shares of common stock to Mr. Li and Ms. Wang for debt repayment and salary payment for an aggregate amount of $3,141,000 (See Note 6).   The Company issued 1,650,000 shares of common stock to sixteen individual shareholders at $0.8 per share for an aggregate amount of $1,320,000 during the nine months ended September 30, 2016, $560,341 of which has not been received by the Company as of September 30, 2016 and has been recorded in the account of stock subscription receivable.   During the nine months ended September 30, 2016, the Company issued 1,710,808 shares of common stock to three consulting companies for the investor relation consulting service and four individuals for the growth and development strategy consulting service in China, which represents the amount of $1,688,300 based on quoted price at issuance. The Company amortized the consulting fee over the service periods per agreements. For the nine months ended September 30, 2016, the amortization of consulting expense was $57,717.   The Company also issued 101,947 shares of common stock to Jimmy Zhou, prior CEO of the Company, to settle the partial salary payable of $50,974 owed to Jimmy Zhou in August, 2016.

11. Stock-based Compensation   On December 12, 2006, the Company granted options for 2,000,000 shares of its common stock under its 2004 Stock Incentive Plan. Summary of options issued and outstanding at September 30, 2016 and the movements during the nine months then ended are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Number of underlying shares</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted- Average Exercise Price Per Share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Aggregate Intrinsic Value (1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Weighted- Average Contractual Life Remaining in Years</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 49%; line-height: 115%">Outstanding at December 31, 2015</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 9%; text-align: right; line-height: 115%">6,163</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">35</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 10%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 10%; text-align: right; line-height: 115%">1</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Expired</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; text-align: justify; line-height: 115%">Forfeited</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Outstanding at September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">6,163</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">35</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Exercisable at September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,163</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">35</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">0.25</td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">(1) </td> <td style="text-align: justify; line-height: 115%">The market value of the Company’s common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.</td></tr> </table>

12. Commitments and Contingencies   The Company has the following material contractual obligations:   Operation of Kiwa-CAU R&D Center   Pursuant to the agreement on joint incorporation of the research and development center between CAU and Kiwa Shandong dated November 14, 2006, Kiwa Shandong agrees to invest RMB1 million (approximately $160,000) each year to fund research at the R&D Center. The term of this Agreement is ten years starting from July 1, 2006. Qi Wang, one of our directors commencing in July 2007 has acted as Director of Kiwa-CAU R&D Center since July 2006.   CAAS IARRP and IAED Institutes   On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 Million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.   Investment in manufacturing and research facilities in Zoucheng, Shandong Province in China   According to the Project Agreement with Zoucheng Municipal Government in 2002, the Company has committed to investing approximately $18 million to $24 million for developing the manufacturing and research facilities in Zoucheng, Shandong Province. The Company had invested approximately $2 million for the project during the period from 2004 to 2010 and no additional investments were made since then.

13. Income Tax   In accordance with the current tax laws in China, the company’s subsidiaries in china are subject to a corporate income tax rate of 25% on its taxable income.   No provision for U.S. income taxes is made as the Company has no taxable income in the U.S. In accordance with the relevant tax laws in the British Virgin Islands, Kiwa BVI, as an International Business Company, is exempt from income taxes.   A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid"> Nine months ended September 30,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 115%">Pre-tax income (loss)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">410,652</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="width: 16%; border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(480,051</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">U.S. federal corporate income tax rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34</td> <td style="line-height: 115%">%</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34</td> <td style="line-height: 115%">%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Income tax computed at U.S. federal corporate income tax rate</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">139,622</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(163,217</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Reconciling items:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Rate differential for PRC earnings</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(14,043)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">17,465</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Change of valuation allowance</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">220,518</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">115,152</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Non-deductible expenses (Non-taxable income)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(267,152</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,600</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Effective tax expense</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">78,945</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   The provisions for income taxes are summarized as follows:       <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nine months ended September 30,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Current</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">78,945</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Deferred</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">78,945</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   The Company had deferred tax assets as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">September 30, 2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; text-align: justify; line-height: 115%">Net operating losses carried forward</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">3,511,402</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">3,398,402</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: justify; line-height: 115%">Less: Valuation allowance</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(3,511,402</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(3,398,402</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: justify; line-height: 115%">Net deferred tax assets</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>   The net operating losses carried forward were approximately $8.66 million at September 30, 2016, which will expire between 2016 and 2026. Full valuation allowance has been made because it is considered more likely than not that the deferred tax assets will not be realized through sufficient future earnings of the entity to which the operating losses relate.

14. Subsequent Event   The Company has evaluated subsequent events through the date that these financial statements were issued and determined that there were no subsequent events to disclose in these financial statements.

Principle of consolidation - These consolidated financial statements include the financial statements of the Company and its wholly-owned subsidiaries. All significant inter-company balances or transactions are eliminated on consolidation.

Basis of preparation - These interim consolidated financial statements are unaudited. In the opinion of management, all adjustments (consisting solely of normal recurring adjustments) and disclosures necessary for a fair presentation of these interim condensed consolidated financial statements have been included. The results reported in the consolidated financial statements for any interim periods are not necessarily indicative of the results that may be reported for the entire year or any other periods. The (a) consolidated balance sheet as of December 31, 2015, which was derived from audited financial statements, and (b) the unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and accompanying footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015.

Reverse Split - On January 14, 2016, the Company filed a Certificate of Amendment of its Certificate of Incorporation with the State of Delaware with reference to a 1-for-200 reverse stock split with respect to its Common Stock with effective date of January 28, 2016. In connection with the reverse split, the Company’s authorized capital stock was amended to be 120,000,000 shares, comprising 100,000,000 shares of Common Stock par value $0.001 and 20,000,000 shares of Preferred Stock par value $0.001. All relevant information relating to numbers of shares, options and per share information have been retrospectively adjusted to reflect the reverse stock split for all periods presented.

Use of Estimates - The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant accounting estimates include the bad debt provision, impairment of long-lived assets, depreciation and amortization, valuation allowance of deferred tax assets and fair value of warrants and options.

Foreign Currency Translation - The Company uses United States dollars (“US Dollar” or “US$” or “$”) for financial reporting purposes. However, the Company maintains the books and records in its functional currency, Chinese Renminbi (“RMB”), being the primary currency of the economic environment in which its operations are conducted. In general, the Company translates its assets and liabilities into U.S. dollars using the applicable exchange rates prevailing at the balance sheet date, and the statement of income is translated at average exchange rates during the reporting period. Equity accounts are translated at historical rates. Adjustments resulting from the translation of the Company’s financial statements are recorded as accumulated other comprehensive income.   The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; padding-left: 8.7pt; text-align: center; line-height: 115%; text-indent: -8.7pt">As of September 30, 2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">As of December 31, 2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify; line-height: 115%">Balance sheet items, except for equity accounts</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.6714</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.4857</td> <td style="width: 1%; line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td colspan="5" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nine months ended September 30,</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 58%; text-align: justify; line-height: 115%">Items in the statements of income and cash flows</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.5806</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 18%; text-align: center; line-height: 115%">US$1 = RMB 6.1735</td> <td style="width: 1%; line-height: 115%"> </td></tr> </table>

Impairment of Long-Lived Assets - We periodically evaluate our investment in long-lived assets, including property and equipment, for recoverability whenever events or changes in circumstances indicate the net carrying amount may not be recoverable. Our judgments regarding potential impairment are based on legal factors, market conditions and operational performance indicators, among others. In assessing the impairment of property and equipment, we make assumptions regarding the estimated future cash flows and other factors to determine the fair value of the respective assets. Based on our analysis, no further impairment of long-lived assets was charged during the nine months ended September 30, 2016.

Revenue Recognition - The Companys revenue includes two parts: Part I represents fees per licensing agreement. The Company entered into an agreement with a company, Kangtan Gerui (Beijing) Bio-Tech Co., Ltd. (Gerui), to allow Gerui sell products with the Companys trademark. Gerui will pay 10% of total sales amount to the Company as license fee.   Part II represents the revenues from sales of products purchased. The Company recognized license fees and revenue from sales of products when a formal arrangement exists, the price is fixed or determinable, the delivery is completed, and no other significant obligations of the Company exist and collectability is reasonably assured. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as advances from customers.

Accounts Receivables - Accounts receivables represent customer accounts receivables. The allowance for doubtful accounts is based on a combination of current sales, historical charge offs and specific accounts identified as high risk. Uncollectible accounts receivable are charged against the allowance for doubtful accounts when all reasonable efforts to collect the amounts due have been exhausted. Such allowances, if any, would be recorded in the period the impairment is identified.

Income Taxes - The Company accounts for income taxes under the provisions of FASB ASC Topic 740, “Income Tax,” which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Deferred tax assets and liabilities are recognized for the future tax consequence attributable to the difference between the tax bases of assets and liabilities and their reported amounts in the financial statements. Deferred tax assets and liabilities are measured using the enacted tax rate expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company establishes a valuation when it is more likely than not that the assets will not be recovered.

Fair value measurements - ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value. There are three levels of inputs that may be used to measure fair value:   Level 1 - Quoted prices in active markets for identical assets or liabilities.   Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.   Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The carrying values of cash and cash equivalents, trade receivables and payables, and short-term debts approximate their fair values due to their short maturities.   There were no assets and liabilities measured at fair value on a nonrecurring basis as of September 30, 2016 and December 31, 2015.

The provisions for income taxes are summarized as follows:       <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Nine months ended September 30,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2015</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%; line-height: 115%">Current</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">78,945</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 16%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Deferred</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">78,945</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> </table>

67500

22500

The market value of the Company's common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.

EX-101.SCH 7 kwbt-20160930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Description of Business and Organization link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Going Concern link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summaries of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Prepaid Expenses link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Advance to Customer - Gerui link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions and Balances link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Other Payable link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Convertible Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Note Payable link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Stock-based Compensation link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Income Tax link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summaries of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summaries of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Stock-based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Income Tax (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Description of Business and Organization (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Going Concern (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Prepaid expenses (Deatils Narrative) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Advance to customer - Gerui (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Other Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Convertible Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Note Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Stockholders' Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Stock-based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Commitments and Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Income Tax (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Income Tax - Schedule of Provision for Income Tax (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Income Tax - Schedule of Deferred Tax Assets (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 kwbt-20160930_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 kwbt-20160930_def.xml XBRL DEFINITION FILE EX-101.LAB 10 kwbt-20160930_lab.xml XBRL LABEL FILE Balance Sheet Items, Except For Equity Accounts [Member] Income Statement Location [Axis] RMB [Member] Currency [Axis] Items Statements of Income and CashFlows [Member] Mr. Wei Li [Member] Related Party [Axis] Non-Trade Transaction [Member] Related Party Transaction [Axis] Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. [Member] Kiwa-CAU R&D Center [Member] Trade Transaction [Member] Ms. Yvonne Wang [Member] 2004 Stock Incentive Plan [Member] Plan Name [Axis] Zoucheng, Shandong Province [Member] Legal Entity [Axis] Minimum [Member] Range [Axis] Maximum [Member] Title of Individual [Axis] Ms Yvonne Wang [Member] Kangtai International Logistics (Beijing) Co Ltd [Member] CAAS IARRP and IAED Institutes [Member] Two Institutes In China [Member] 6% Notes [Member] Debt Instrument [Axis] Intellectual Property [Member] Finite-Lived Intangible Assets by Major Class [Axis] Unrelated Individual [Member] Investlink (China) Limited [Member] Firs Trust Group Inc [Member] Kangtan Gerui [Member] Mr. Wei Li [Member] Ms. Wang [Member] Baina Hong Kong Shareholders [Member] Sixteen Shareholders [Member] Non-Related-Parties [Member] Jimmy Zhou [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement of Financial Position [Abstract] ASSETS Current assets Cash and cash equivalents Accounts receivable Prepaid expenses Advance to customer - Gerui Other current assets Total current assets Property, plant and equipment - net Rent and utility deposits Intangible assets Total assets LIABILITIES AND STOCKHOLDERS' DEFICIENCY Current liabilities Accounts payable Advances from customers Construction costs payable Due to related parties - trade Due to related parties - non-trade Convertible notes payable Notes payable Salary payable Taxes payable Penalty payable Interest payable Other payable Accrued expenses and other current liabilities Total current liabilities Unsecured loans payable Total long-term liabilities Total liabilities Stockholders' deficiency Preferred stock - $0.001 par value. Authorized 20,000,000 shares. Issued outstanding 500,000 shares at September 30, 2016 and December 31, 2015, respectively Common stock - $0.001 par value. Authorized 100,000,000 shares. Issued and outstanding 8,603,981 and 2,000,000 shares at September 30, 2016 and December 31, 2015, respectively. Additional paid-in capital Stock subscription receivable Accumulated deficit Accumulated other comprehensive loss Total stockholders' deficiency Total liabilities and stockholders' deficiency Preferred Stock, par value Preferred Stock, shares authorized Preferred Stock, shares issued Preferred Stock, shares outstanding Common Stock, par value Common Stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Income Statement [Abstract] Revenue Cost of revenue Gross profit Operating expenses General and administrative Research and development Total operating expenses Operating income (loss) Other expense Penalty expense Interest expense Total other expense Income (loss) before income tax provision Income tax provision Net income (loss) Other comprehensive income Foreign currency translation adjustment Comprehensive income (loss) Net income(loss) per common share - basic Net income(loss) per common share - diluted Weighted average number of common shares outstanding - basic Weighted average number of common shares outstanding - diluted Statement of Cash Flows [Abstract] Cash flows from operating activities: Net income (loss) Adjustments to reconcile net income (loss) to net cash used in operating activities: Depreciation and amortization Provision for penalty payable Accrued interest on convertible notes Issuance of common shares for service Changes in operating assets and liabilities: Accounts receivable Prepaid expenses Advance to customer - Gerui Other current assets Rent and utility deposits Salary payable Taxes payable Due to related parties - trade Accounts payable Other payable Net cash used in operating activities Cash flows from investing activities: Purchase of property, plant and equipment Net cash used by investing activities Cash flows from financing activities: Proceeds from related parties, net of payments to related parties Proceeds from sale of common stock Net cash provided by financing activities Effect of exchange rate change Cash and cash equivalents: Net increase (decrease) Balance at beginning of period Balance at end of period Non-cash financing activities: Issuance of 3,141,000 shares of common stock for repayment of related party loans Issuance of 101,947 shares of common stock for payment of accrued salaries Issuance of 1,710,808 shares of common stock for prepaid consulting services Advances from related parties to pay for acquisition of intangible assets Supplemental Disclosures of Cash flow Information: Cash paid for interest Cash paid for income taxes Number of shares issuance of common stock Number of shares issuance for payment of accrued salaries Number of shares issuance for prepaid consulting services Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business and Organization Going Concern Accounting Policies [Abstract] Summaries of Significant Accounting Policies Prepaid Expense and Other Assets [Abstract] Prepaid Expenses Receivables [Abstract] Advance to Customer - Gerui Related Party Transactions [Abstract] Related Party Transactions and Balances Other Liabilities Disclosure [Abstract] Other Payable Debt Disclosure [Abstract] Convertible Notes Payable Note Payable Equity [Abstract] Stockholders' Equity Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Stock-based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Income Tax Disclosure [Abstract] Income Tax Subsequent Events [Abstract] Subsequent Events EX-101.PRE 11 kwbt-20160930_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Sep. 30, 2016	Nov. 18, 2016
Document And Entity Information
Entity Registrant Name	KIWA BIO-TECH PRODUCTS GROUP CORP
Entity Central Index Key	0001159275
Document Type	10-Q
Document Period End Date	Sep. 30, 2016
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		8,603,981
Trading Symbol	KWBT
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2016

XML 13 R2.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents	$ 545	$ 721
Accounts receivable	1,224,410
Prepaid expenses	1,639,583
Advance to customer - Gerui	1,677,459
Other current assets	58,432	47,453
Total current assets	4,600,429	48,174
Property, plant and equipment - net	69,652	2,807
Rent and utility deposits	37,295
Intangible assets	34,112
Total assets	4,741,488	50,981
Current liabilities
Accounts payable	1,076,266	300,247
Advances from customers	13,415	13,800
Construction costs payable	266,103	273,722
Due to related parties - trade	1,337,489	1,143,978
Due to related parties - non-trade	107,710	3,166,198
Convertible notes payable	150,250	150,250
Notes payable	360,000	360,000
Salary payable	1,675,900	1,632,881
Taxes payable	586,958	478,209
Penalty payable	462,423	404,752
Interest payable	1,014,480	930,062
Other payable	479,659
Accrued expenses and other current liabilities	512,003	524,205
Total current liabilities	8,042,656	9,378,304
Unsecured loans payable	1,723,776	1,773,131
Total long-term liabilities	1,723,776	1,773,131
Total liabilities	9,766,432	11,151,435
Stockholders' deficiency
Preferred stock - $0.001 par value. Authorized 20,000,000 shares. Issued outstanding 500,000 shares at September 30, 2016 and December 31, 2015, respectively	500	500
Common stock - $0.001 par value. Authorized 100,000,000 shares. Issued and outstanding 8,603,981 and 2,000,000 shares at September 30, 2016 and December 31, 2015, respectively.	8,604	2,000
Additional paid-in capital	15,684,507	9,490,837
Stock subscription receivable	(560,341)
Accumulated deficit	(19,993,105)	(20,324,812)
Accumulated other comprehensive loss	(165,109)	(268,979)
Total stockholders' deficiency	(5,024,944)	(11,100,454)
Total liabilities and stockholders' deficiency	$ 4,741,488	$ 50,981

XML 14 R3.htm IDEA: XBRL DOCUMENT

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred Stock, par value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	20,000,000	20,000,000
Preferred Stock, shares issued	500,000	500,000
Preferred Stock, shares outstanding	500,000	500,000
Common Stock, par value	$ 0.001	$ 0.001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	8,603,981	2,000,000
Common Stock, shares outstanding	8,603,981	2,000,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Statement [Abstract]
Revenue	$ 1,261,544		$ 1,971,639
Cost of revenue	(770,451)		(770,451)
Gross profit	491,093		1,201,188
Operating expenses
General and administrative	196,019	72,968	421,688	220,510
Research and development	74,783	39,860	226,552	121,487
Total operating expenses	270,802	112,828	648,240	341,997
Operating income (loss)	220,291	(112,828)	552,948	(341,997)
Other expense
Penalty expense	19,564	18,208	57,672	53,605
Interest expense	28,181	28,189	84,624	84,449
Total other expense	47,745	46,397	142,296	138,054
Income (loss) before income tax provision	172,546	(159,225)	410,652	(480,051)
Income tax provision	78,945		78,945
Net income (loss)	93,601	(159,225)	331,707	(480,051)
Other comprehensive income
Foreign currency translation adjustment	9,765	327,472	103,870	278,566
Comprehensive income (loss)	$ 103,366	$ 168,247	$ 435,577	$ (201,485)
Net income(loss) per common share - basic	$ 0.01	$ (0.08)	$ 0.07	$ (0.24)
Net income(loss) per common share - diluted	$ 0.01	$ (0.08)	$ 0.04	$ (0.24)
Weighted average number of common shares outstanding - basic	6,300,700	2,000,000	4,617,535	2,000,000
Weighted average number of common shares outstanding - diluted	7,064,969	2,000,000	7,769,954	2,000,000

XML 16 R5.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ 331,707	$ (480,051)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	13,039	3,293
Provision for penalty payable	57,672	53,605
Accrued interest on convertible notes	84,418	84,357
Issuance of common shares for service	57,717
Changes in operating assets and liabilities:
Accounts receivable	(1,240,550)
Prepaid expenses	(7,500)
Advance to customer - Gerui	(1,700,605)
Other current assets	(11,988)
Rent and utility deposits	(37,809)
Salary payable	93,993	110,604
Taxes payable	123,604	47,604
Due to related parties - trade	226,392	121,487
Accounts payable	794,868
Other payable	477,284	(18,752)
Net cash used in operating activities	(737,758)	(77,853)
Cash flows from investing activities:
Purchase of property, plant and equipment	(79,604)
Net cash used by investing activities	(79,604)
Cash flows from financing activities:
Proceeds from related parties, net of payments to related parties	51,500	77,988
Proceeds from sale of common stock	766,281
Net cash provided by financing activities	817,781	77,988
Effect of exchange rate change	(595)	(18)
Cash and cash equivalents:
Net increase (decrease)	(176)	117
Balance at beginning of period	721	2,963
Balance at end of period	545	3,080
Non-cash financing activities:
Issuance of 3,141,000 shares of common stock for repayment of related party loans	3,141,000
Issuance of 101,947 shares of common stock for payment of accrued salaries	50,974
Issuance of 1,710,808 shares of common stock for prepaid consulting services	1,630,583
Advances from related parties to pay for acquisition of intangible assets	34,112
Supplemental Disclosures of Cash flow Information:
Cash paid for interest
Cash paid for income taxes

XML 17 R6.htm IDEA: XBRL DOCUMENT

Consolidated Statements of Cash Flows (Parenthetical) - shares	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Statement of Cash Flows [Abstract]
Number of shares issuance of common stock	3,141,000	3,141,000
Number of shares issuance for payment of accrued salaries	101,947	101,947
Number of shares issuance for prepaid consulting services	1,710,808	1,710,808

XML 18 R7.htm IDEA: XBRL DOCUMENT

Description of Business and Organization

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business and Organization

1. Description of Business and Organization

References herein to “Kiwa” or the “Company” refer to Kiwa Bio-Tech Products Group Corporation and its wholly-owned subsidiaries unless the context specifically states or implies otherwise.

XML 19 R8.htm IDEA: XBRL DOCUMENT

Going Concern

9 Months Ended

Sep. 30, 2016

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Going Concern

2. Going Concern

XML 20 R9.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Summaries of Significant Accounting Policies

3. Summaries of Significant Accounting Policies

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:

			As of September 30, 2016				As of December 31, 2015
Balance sheet items, except for equity accounts			US$1 = RMB 6.6714				US$1 = RMB 6.4857

	Nine months ended September 30,
	2016	2015
Items in the statements of income and cash flows	US$1 = RMB 6.5806	US$1 = RMB 6.1735

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying values of cash and cash equivalents, trade receivables and payables, and short-term debts approximate their fair values due to their short maturities.

There were no assets and liabilities measured at fair value on a nonrecurring basis as of September 30, 2016 and December 31, 2015.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Prepaid Expenses

9 Months Ended

Sep. 30, 2016

Prepaid Expense and Other Assets [Abstract]

Prepaid Expenses

4. Prepaid expenses

XML 22 R11.htm IDEA: XBRL DOCUMENT

Advance to Customer - Gerui

9 Months Ended

Sep. 30, 2016

Receivables [Abstract]

Advance to Customer - Gerui

5. Advance to customer - Gerui

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions and Balances

9 Months Ended

Sep. 30, 2016

Related Party Transactions and Balances

6. Related Party Transactions and Balances

Amounts due to related parties consisted of the following:

Item

Nature

Notes

September 30, 2016

December 31, 2015

Mr. Wei Li (“Mr. Li”)

Non-trade

(1)

2,879,307

Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. (“Kangtai”)

Non-trade

(2)

(12,173

)

Ms. Yvonne Wang (“Ms. Wang”)

Non-trade

(3)

107,710

299,064

Subtotal

107,710

3,166,198

Kiwa-CAU R&D Center

Trade

(4)

1,206,644

1,125,553

CAAS IARRP and IAED Institutes

Trade

(5)

130,845

18,425

Subtotal

1,337,489

1,143,978

Total

1,445,199

4,310,176

(1) Mr. Li

Mr. Li was the Chairman of the Board until November 20, 2015 and was the Chief Executive Officer of the Company until July 1, 2015.

Advances and Loans

Guarantees for the Company

Mr. Li has pledged without any compensation from the Company, all of his common stock of the Company as collateral security for the Company’s obligations under the 6% Notes. (See Note 8 below).

(2) Kangtai

On December 31, 2015, the amount due from Kangtai was $12,173. The balance due from Kangtai on September 30, 2016 was nil.

(3) Ms. Wang

(4) Kiwa-CAU R&D Center

On December 31, 2015, the amount due to Kiwa-CAU R&D Center was $1,125,553. As of September 30, 2016, the outstanding balance due to Kiwa-CAU R&D Center was $1,206,644.

(5) CAAS IARRP and IAED Institutes

XML 24 R13.htm IDEA: XBRL DOCUMENT

Other Payable

9 Months Ended

Sep. 30, 2016

Other Liabilities Disclosure [Abstract]

Other Payable

7. Other Payable

XML 25 R14.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Convertible Notes Payable

8. Convertible Notes Payable

XML 26 R15.htm IDEA: XBRL DOCUMENT

Note Payable

9 Months Ended

Sep. 30, 2016

Debt Disclosure [Abstract]

Note Payable

9. Note payable

XML 27 R16.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

9 Months Ended

Sep. 30, 2016

Equity [Abstract]

Stockholders' Equity

10. Stockholders’ Equity

The Company also issued 101,947 shares of common stock to Jimmy Zhou, prior CEO of the Company, to settle the partial salary payable of $50,974 owed to Jimmy Zhou in August, 2016.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74567-122707

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB Topic 4.C)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

+ Details

XML 28 R17.htm IDEA: XBRL DOCUMENT

Stock-based Compensation

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based Compensation

11. Stock-based Compensation

	Number of underlying shares		Weighted- Average Exercise Price Per Share		Aggregate Intrinsic Value (1)		Weighted- Average Contractual Life Remaining in Years
Outstanding at December 31, 2015		6,163	$	35	$	-		1
Exercised		-		-
Expired		-		-		-
Forfeited		-		-		-
Outstanding at September 30, 2016		6,163	$	35	$	-		0.25

Exercisable at September 30, 2016		6,163	$	35	$	-		0.25

(1)	The market value of the Company’s common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References + Details

XML 29 R18.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

9 Months Ended

Sep. 30, 2016

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

The Company has the following material contractual obligations:

Operation of Kiwa-CAU R&D Center

CAAS IARRP and IAED Institutes

On November 5, 2015, the Company signed a strategic cooperation agreement (the “Agreement”) with China Academy of Agricultural Science (“CAAS”)’s Institute of Agricultural Resources & Regional Planning (“IARRP”) and Institute of Agricultural Economy & Development (“IAED”). Pursuant to the Agreement, the Company will form a strategic partnership with the two institutes and establish an “International Cooperation Platform for Internet and Safe Agricultural Products”. To fund the cooperation platform’s R&D activities, the Company will provide RMB 1 Million (approximately $160,000) per year to the Spatial Agriculture Planning Method & Applications Innovation Team that belongs to the Institutes. The term of the Agreement is for three years beginning November 20, 2015. Prof Yong Chang Wu, the authorized representative of IARRP, CAAS, is also one of the Company’s directors effective since November 20, 2015.

Investment in manufacturing and research facilities in Zoucheng, Shandong Province in China

XML 30 R19.htm IDEA: XBRL DOCUMENT

Income Tax

9 Months Ended

Sep. 30, 2016

Income Tax Disclosure [Abstract]

Income Tax

13. Income Tax

In accordance with the current tax laws in China, the company’s subsidiaries in china are subject to a corporate income tax rate of 25% on its taxable income.

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Nine months ended September 30,
	2016			2015
Pre-tax income (loss)	$	410,652		$	(480,051	)

U.S. federal corporate income tax rate		34	%		34	%
Income tax computed at U.S. federal corporate income tax rate		139,622			(163,217	)
Reconciling items:
Rate differential for PRC earnings		(14,043)			17,465
Change of valuation allowance		220,518			115,152
Non-deductible expenses (Non-taxable income)		(267,152	)		30,600
Effective tax expense	$	78,945		$	-

The provisions for income taxes are summarized as follows:

	Nine months ended September 30,
	2016		2015
Current	$	78,945	$	-
Deferred		-		-
Total	$	78,945	$	-

The Company had deferred tax assets as follows:

	September 30, 2016			December 31, 2015
Net operating losses carried forward	$	3,511,402		$	3,398,402
Less: Valuation allowance		(3,511,402	)		(3,398,402	)
Net deferred tax assets	$	-		$	-

XML 31 R20.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Sep. 30, 2016

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Event

The Company has evaluated subsequent events through the date that these financial statements were issued and determined that there were no subsequent events to disclose in these financial statements.

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Principle of Consolidation

Basis of Preparation

Reverse Split

Use of Estimates

Foreign Currency Translation

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:

			As of September 30, 2016				As of December 31, 2015
Balance sheet items, except for equity accounts			US$1 = RMB 6.6714				US$1 = RMB 6.4857

	Nine months ended September 30,
	2016	2015
Items in the statements of income and cash flows	US$1 = RMB 6.5806	US$1 = RMB 6.1735

Impairment of Long-Lived Assets

Revenue Recognition

Accounts Receivables

Income Taxes

Fair Value Measurements

Level 1 - Quoted prices in active markets for identical assets or liabilities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The carrying values of cash and cash equivalents, trade receivables and payables, and short-term debts approximate their fair values due to their short maturities.

There were no assets and liabilities measured at fair value on a nonrecurring basis as of September 30, 2016 and December 31, 2015.

XML 33 R22.htm IDEA: XBRL DOCUMENT

Summaries of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2016

Accounting Policies [Abstract]

Schedule of Foreign Currency Exchange Rate

The exchange rates used to translate amounts in RMB into U.S. Dollars for the purposes of preparing the condensed consolidated financial statements were as follows:

			As of September 30, 2016				As of December 31, 2015
Balance sheet items, except for equity accounts			US$1 = RMB 6.6714				US$1 = RMB 6.4857

	Nine months ended September 30,
	2016	2015
Items in the statements of income and cash flows	US$1 = RMB 6.5806	US$1 = RMB 6.1735

XML 34 R23.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Tables)

9 Months Ended

Sep. 30, 2016

Schedule of Related Party Transactions

Amounts due to related parties consisted of the following:

Item

Nature

Notes

September 30, 2016

December 31, 2015

Mr. Wei Li (“Mr. Li”)

Non-trade

(1)

2,879,307

Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. (“Kangtai”)

Non-trade

(2)

(12,173

)

Ms. Yvonne Wang (“Ms. Wang”)

Non-trade

(3)

107,710

299,064

Subtotal

107,710

3,166,198

Kiwa-CAU R&D Center

Trade

(4)

1,206,644

1,125,553

CAAS IARRP and IAED Institutes

Trade

(5)

130,845

18,425

Subtotal

1,337,489

1,143,978

Total

1,445,199

4,310,176

(1) Mr. Li

Mr. Li was the Chairman of the Board until November 20, 2015 and was the Chief Executive Officer of the Company until July 1, 2015.

Advances and Loans

Guarantees for the Company

Mr. Li has pledged without any compensation from the Company, all of his common stock of the Company as collateral security for the Company’s obligations under the 6% Notes. (See Note 8 below).

(2) Kangtai

On December 31, 2015, the amount due from Kangtai was $12,173. The balance due from Kangtai on September 30, 2016 was nil.

(3) Ms. Wang

(4) Kiwa-CAU R&D Center

On December 31, 2015, the amount due to Kiwa-CAU R&D Center was $1,125,553. As of September 30, 2016, the outstanding balance due to Kiwa-CAU R&D Center was $1,206,644.

(5) CAAS IARRP and IAED Institutes

XML 35 R24.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Stock-based Compensation

Summary of options issued and outstanding at September 30, 2016 and the movements during the nine months then ended are as follows:

	Number of underlying shares		Weighted- Average Exercise Price Per Share		Aggregate Intrinsic Value (1)		Weighted- Average Contractual Life Remaining in Years
Outstanding at December 31, 2015		6,163	$	35	$	-		1
Exercised		-		-
Expired		-		-		-
Forfeited		-		-		-
Outstanding at September 30, 2016		6,163	$	35	$	-		0.25

Exercisable at September 30, 2016		6,163	$	35	$	-		0.25

(1)	The market value of the Company’s common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.

XML 36 R25.htm IDEA: XBRL DOCUMENT

Income Tax (Tables)

9 Months Ended

Sep. 30, 2016

Income Tax Disclosure [Abstract]

Schedule of Reconciliation of U.S. Tax Rate

A reconciliation of the provision for income taxes determined at the local income tax rate to the Company’s effective income tax rate is as follows:

	Nine months ended September 30,
	2016			2015
Pre-tax income (loss)	$	410,652		$	(480,051	)

U.S. federal corporate income tax rate		34	%		34	%
Income tax computed at U.S. federal corporate income tax rate		139,622			(163,217	)
Reconciling items:
Rate differential for PRC earnings		(14,043)			17,465
Change of valuation allowance		220,518			115,152
Non-deductible expenses (Non-taxable income)		(267,152	)		30,600
Effective tax expense	$	78,945		$	-

Schedule of Provision for Income Tax

The provisions for income taxes are summarized as follows:

	Nine months ended September 30,
	2016		2015
Current	$	78,945	$	-
Deferred		-		-
Total	$	78,945	$	-

Schedule of Deferred Tax Assets

The Company had deferred tax assets as follows:

	September 30, 2016			December 31, 2015
Net operating losses carried forward	$	3,511,402		$	3,398,402
Less: Valuation allowance		(3,511,402	)		(3,398,402	)
Net deferred tax assets	$	-		$	-

XML 37 R26.htm IDEA: XBRL DOCUMENT

Description of Business and Organization (Details Narrative) - Baina Hong Kong Shareholders [Member]	1 Months Ended
	Nov. 30, 2015 USD ($)
Payments to acquire equity	$ 30,000
Percentage of equity interest rate	100.00%
Goodwill	$ 34,000

XML 38 R27.htm IDEA: XBRL DOCUMENT

Going Concern (Details Narrative) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 545
Working capital deficiency	3,442,227
Accumulated deficit	19,993,105	$ 20,324,812
Stockholders' deficiency	$ 5,024,944	$ 11,100,454

XML 39 R28.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)		3 Months Ended	9 Months Ended
	Jan. 14, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Reverse stock split	1-for-200
Authorized capital	120,000,000
Common Stock, shares authorized	100,000,000		100,000,000		100,000,000
Common Stock, par value	$ 0.001		$ 0.001		$ 0.001
Preferred Stock, shares authorized	20,000,000		20,000,000		20,000,000
Preferred Stock, par value	$ 0.001		$ 0.001		$ 0.001
Accrued interest expense		$ 22,500		$ 67,500
Kangtan Gerui [Member]
Percentage pay of sales amount to license fee			10.00%

XML 40 R29.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) - RMB [Member]	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015
Balance Sheet Items, Except For Equity Accounts [Member]
Foreign currency exchange rate, translation	6.6714	6.4857
Items Statements of Income and CashFlows [Member]
Foreign currency exchange rate, translation	6.5806		6.1735

XML 41 R30.htm IDEA: XBRL DOCUMENT

Prepaid expenses (Deatils Narrative)	9 Months Ended
Prepaid expenses (Deatils Narrative)	Sep. 30, 2016 USD ($) shares
Prepaid Expense and Other Assets [Abstract]
Number of common stock shares issued for consulting service \| shares	1,710,808
Issuance of common stock value	$ 1,688,300
Amortization of consulting expense	$ 57,717

XML 42 R31.htm IDEA: XBRL DOCUMENT

Advance to customer - Gerui (Details Narrative) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Receivables [Abstract]
Advance to customer-Gerui	$ 1,677,459

XML 43 R32.htm IDEA: XBRL DOCUMENT

Related Party Transactions (Details Narrative)			9 Months Ended	12 Months Ended
Related Party Transactions (Details Narrative)	Mar. 24, 2016 shares	Nov. 14, 2006 CNY (¥)	Sep. 30, 2016 USD ($) shares	Dec. 31, 2015 USD ($) shares
Ms Yvonne Wang [Member]
Related Party Transaction [Line Items]
Number of common stock shares issued for repayment of debt \| shares	240,000
Repayment of aggregate debt owing to issues			$ 240,000
Due to related parties				$ 299,064
Behalf of company payments			107,710
Kiwa-CAU R&D Center [Member]
Related Party Transaction [Line Items]
Due to related parties				1,125,553
Related party transation amount			160,000
Outstanding balance			1,206,644
Kiwa-CAU R&D Center [Member] \| RMB [Member]
Related Party Transaction [Line Items]
Related party transation amount		¥ 1,000,000	1,000,000
CAAS IARRP and IAED Institutes [Member]
Related Party Transaction [Line Items]
Due to related parties				$ 18,425
Related party transation amount			160,000
Outstanding balance			130,845
CAAS IARRP and IAED Institutes [Member] \| RMB [Member]
Related Party Transaction [Line Items]
Related party transation amount			1,000,000
Mr. Wei Li [Member]
Related Party Transaction [Line Items]
Number of common stock shares issued for repayment of debt \| shares				2,879,307
Repayment of aggregate debt owing to issues			$ 2,879,307
Stock Repurchased ,shares \| shares			2,900,000
Debt instrument, interest rate			6.00%
Mr. Wei Li [Member] \| Kangtai International Logistics (Beijing) Co Ltd [Member]
Related Party Transaction [Line Items]
Due from related parties
Mr. Wei Li [Member] \| Kangtai International Logistics (Beijing) Co Ltd [Member]
Related Party Transaction [Line Items]
Percentage of ownership				28.00%
Due from related parties				$ 12,173

XML 44 R33.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Schedule of Related Party Transactions (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Related Party Transaction [Line Items]
Due to related parties - non-trade	$ 107,710	$ 3,166,198
Due to related parties - trade	1,337,489	1,143,978
Total	1,445,199	4,310,176
Mr. Wei Li [Member] \| Non-Trade Transaction [Member]
Related Party Transaction [Line Items]
Remaining advances and loans		2,879,307
Kangtai Xinnong Agriculture Tech (Beijing) Co., Ltd. [Member] \| Non-Trade Transaction [Member]
Related Party Transaction [Line Items]
Due to other related party		(12,173)
Ms. Yvonne Wang [Member] \| Non-Trade Transaction [Member]
Related Party Transaction [Line Items]
Due to employees	10,710	299,064
Kiwa-CAU R&D Center [Member] \| Trade Transaction [Member]
Related Party Transaction [Line Items]
Due to other related party	1,206,644	1,125,553
CAAS IARRP and IAED Institutes [Member] \| Trade Transaction [Member]
Related Party Transaction [Line Items]
Due to other related party	$ 130,845	$ 18,425

XML 45 R34.htm IDEA: XBRL DOCUMENT

Other Payable (Details Narrative)	Sep. 30, 2016 USD ($)
Non-Related-Parties [Member]
Payments to investors	$ 479,659

XML 46 R35.htm IDEA: XBRL DOCUMENT

Convertible Notes Payable (Details Narrative) - USD ($)		9 Months Ended
Convertible Notes Payable (Details Narrative) - USD ($)	Jun. 29, 2006	Sep. 30, 2016	Sep. 30, 2015
6% Notes [Member] \| Intellectual Property [Member]
Pledged assets, not separately reported, other		$ 592,901
Impairment of intangible assets, finite-lived		179,897
Firs Trust Group Inc [Member]
Accrued interest expense		16,919	$ 16,857
Accrued penalty		$ 57,672	$ 53,605
Firs Trust Group Inc [Member] \| 6% Notes [Member]
Percentage of secured convertible notes issued	6.00%
Notes beard interest	6.00%
Debt instruments maturity date	Jun. 29, 2009
Interest rate increased	15.00%
Percentage of conversion price	6.00%
Percentage of discount to average of trading price	40.00%
Maximum percentage of affiliates to hold outstanding common stock	4.99%
Debt instruments face amount	$ 120,000
Percentage of equal shares purchaser entitled to multiplied by market price for each day	2.00%
Percentage of stock issuable upon full conversion of notes and warrants	110.00%

XML 47 R36.htm IDEA: XBRL DOCUMENT

Note Payable (Details Narrative) - USD ($)		9 Months Ended
Note Payable (Details Narrative) - USD ($)	May 29, 2007	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Promissory note		$ 360,000		$ 360,000
Accrued interest expense		$ 67,500	$ 67,500
Unrelated Individual [Member]
Promissory note	$ 360,000
Note interest rate	18.00%
Note maturity date	Jul. 27, 2007
Note default rate	25.00%
Investlink (China) Limited [Member]
Note is secured by pledge shares of common stock	6,178,336
Post-reverse split shares	30,892

XML 48 R37.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
Stockholders' Equity (Details Narrative) - USD ($)	Aug. 31, 2016	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Salary payment		$ 3,141,000
Common stock issued,shares		3,141,000	3,141,000
Stock subscription receivable		$ (560,341)
Number of common stock shares issued for consulting service		1,710,808
Issuance of common stock value		$ 1,688,300
Amortization of consulting expense		$ 57,717
Sixteen Shareholders [Member]
Common stock issued,shares		1,650,000
Common stock price per share		$ 0.8
Common stock issued,values		$ 1,320,000
Mr. Wei Li [Member]
Number of common stock shares issued		3,140,000
Ms. Wang [Member]
Debt repayment for the amount		$ 3,141,000
Jimmy Zhou [Member]
Salary payment	$ 50,974
Common stock issued,shares	101,947

XML 49 R38.htm IDEA: XBRL DOCUMENT

Stock-based Compensation (Details Narrative)	Dec. 12, 2006 shares
2004 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock based compensation, granted options shares	2,000,000

XML 50 R39.htm IDEA: XBRL DOCUMENT

Stock-based Compensation - Schedule of Stock-based Compensation (Details)

9 Months Ended

Sep. 30, 2016

USD ($)

$ / shares

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Number of shares, Outstanding, beginning | shares

6,163

Number of shares, Exercised | shares

Number of shares, Expired | shares

Number of shares, Forfeited | shares

Number of shares, Outstanding, ending | shares

6,163

Number of shares, Exercisable, ending | shares

6,163

Weighted-Average Exercise Price Prer Shares, Outstanding, beginning | $ / shares

$ 35

Weighted-Average Exercise Price Prer Shares, Exercised | $ / shares

Weighted-Average Exercise Price Prer Shares, Expired | $ / shares

Weighted-Average Exercise Price Prer Shares, Forfeited | $ / shares

Weighted-Average Exercise Price Prer Shares, Outstanding, ending | $ / shares

Weighted-Average Exercise Price Prer Shares, Exercisable, ending | $ / shares

$ 35

Aggregate Intrinsic Value, outstanding, beginning | $

^[1]

Aggregate Intrinsic Value, Outstanding, ending | $

^[1]

Aggregate Intrinsic Value, Exercisable, ending | $

^[1]

Weighted-Average Contractual Life Remaining Years, Outstanding, beginning

1 year

Weighted-Average Contractual Life Remaining Years, Outstanding, ending

3 months

Weighted-Average Contractual Life Remaining Years, Exercisable, ending

3 months

[1]	The market value of the Company's common stock at September 30, 2016 was $1.43 per share. The outstanding options had no intrinsic value at September 30, 2016.

XML 51 R40.htm IDEA: XBRL DOCUMENT

Stock-based Compensation - Schedule of Stock-based Compensation (Details) (Parenthetical)	Sep. 30, 2016 $ / shares
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Common stock market value per share	$ 1.43

XML 52 R41.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Details Narrative)			9 Months Ended
Commitments and Contingencies (Details Narrative)	Nov. 05, 2015 USD ($)	Nov. 14, 2006 CNY (¥)	Sep. 30, 2016 USD ($)
Kiwa-CAU R&D Center [Member]
Related party transaction, amounts of transaction			$ 160,000
Description of related party transaction			The term of this Agreement is ten years starting from July 1, 2006.
CAAS IARRP and IAED Institutes [Member]
Related party transaction, amounts of transaction			$ 160,000
RMB [Member] \| Kiwa-CAU R&D Center [Member]
Related party transaction, amounts of transaction		¥ 1,000,000	1,000,000
RMB [Member] \| Two Institutes In China [Member]
Related party transaction, amounts of transaction	$ 1,000,000
RMB [Member] \| CAAS IARRP and IAED Institutes [Member]
Related party transaction, amounts of transaction			1,000,000
Zoucheng, Shandong Province [Member]
Investment owned, at cost			2,000,000
Zoucheng, Shandong Province [Member] \| Minimum [Member]
Commitment to investment			18,000,000
Zoucheng, Shandong Province [Member] \| Maximum [Member]
Commitment to investment			$ 24,000,000

XML 53 R42.htm IDEA: XBRL DOCUMENT

Income Tax (Details Narrative)	9 Months Ended
Income Tax (Details Narrative)	Sep. 30, 2016 USD ($)
Income Tax Disclosure [Abstract]
Effective income tax rate	25.00%
Operating loss carry forwards	$ 8,660,000
Operating loss carryforwards expiration term	expire between 2016 and 2026.

XML 54 R43.htm IDEA: XBRL DOCUMENT

Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Pre-tax income (loss)	$ 93,601	$ (159,225)	$ 331,707	$ (480,051)
U.S. federal corporate income tax rate			34.00%	34.00%
Income tax computed at U.S. federal corporate income tax rate			$ 139,622	$ (163,217)
Rate differential for PRC earnings			(14,043)	17,465
Change of valuation allowance			220,518	115,152
Non-deductible expenses (Non-taxable income)			(267,152)	30,600
Effective tax expense	$ 78,945		$ 78,945

XML 55 R44.htm IDEA: XBRL DOCUMENT

Income Tax - Schedule of Provision for Income Tax (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Income Tax Disclosure [Abstract]
Current			$ 78,945
Deferred
Income tax	$ 78,945		$ 78,945

XML 56 R45.htm IDEA: XBRL DOCUMENT

Income Tax - Schedule of Deferred Tax Assets (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Net operating losses carried forward	$ 3,511,402	$ 3,398,402
Less: Valuation allowance	(3,511,402)	(3,398,402)
Net deferred tax assets

EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 61 FilingSummary.xml IDEA: XBRL DOCUMENT 3.5.0.2 html 65 214 1 true 31 0 false 5 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://kiwabiotech.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://kiwabiotech.com/role/BalanceSheets Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://kiwabiotech.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Sheet http://kiwabiotech.com/role/StatementsOfComprehensiveIncomeLoss Consolidated Statements of Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://kiwabiotech.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://kiwabiotech.com/role/StatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 6 false false R7.htm 00000007 - Disclosure - Description of Business and Organization Sheet http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganization Description of Business and Organization Notes 7 false false R8.htm 00000008 - Disclosure - Going Concern Sheet http://kiwabiotech.com/role/GoingConcern Going Concern Notes 8 false false R9.htm 00000009 - Disclosure - Summaries of Significant Accounting Policies Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies Summaries of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Prepaid Expenses Sheet http://kiwabiotech.com/role/PrepaidExpenses Prepaid Expenses Notes 10 false false R11.htm 00000011 - Disclosure - Advance to Customer - Gerui Sheet http://kiwabiotech.com/role/AdvanceToCustomer-Gerui Advance to Customer - Gerui Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions and Balances Sheet http://kiwabiotech.com/role/RelatedPartyTransactionsAndBalances Related Party Transactions and Balances Notes 12 false false R13.htm 00000013 - Disclosure - Other Payable Sheet http://kiwabiotech.com/role/OtherPayable Other Payable Notes 13 false false R14.htm 00000014 - Disclosure - Convertible Notes Payable Notes http://kiwabiotech.com/role/ConvertibleNotesPayable Convertible Notes Payable Notes 14 false false R15.htm 00000015 - Disclosure - Note Payable Sheet http://kiwabiotech.com/role/NotePayable Note Payable Notes 15 false false R16.htm 00000016 - Disclosure - Stockholders' Equity Sheet http://kiwabiotech.com/role/StockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 00000017 - Disclosure - Stock-based Compensation Sheet http://kiwabiotech.com/role/Stock-basedCompensation Stock-based Compensation Notes 17 false false R18.htm 00000018 - Disclosure - Commitments and Contingencies Sheet http://kiwabiotech.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 18 false false R19.htm 00000019 - Disclosure - Income Tax Sheet http://kiwabiotech.com/role/IncomeTax Income Tax Notes 19 false false R20.htm 00000020 - Disclosure - Subsequent Events Sheet http://kiwabiotech.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 00000021 - Disclosure - Summaries of Significant Accounting Policies (Policies) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesPolicies Summaries of Significant Accounting Policies (Policies) Policies http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies 21 false false R22.htm 00000022 - Disclosure - Summaries of Significant Accounting Policies (Tables) Sheet http://kiwabiotech.com/role/SummariesOfSignificantAccountingPoliciesTables Summaries of Significant Accounting Policies (Tables) Tables http://kiwabiotech.com/role/SummariesOfSignificantAccountingPolicies 22 false false R23.htm 00000023 - Disclosure - Related Party Transactions (Tables) Sheet http://kiwabiotech.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://kiwabiotech.com/role/RelatedPartyTransactionsAndBalances 23 false false R24.htm 00000024 - Disclosure - Stock-based Compensation (Tables) Sheet http://kiwabiotech.com/role/Stock-basedCompensationTables Stock-based Compensation (Tables) Tables http://kiwabiotech.com/role/Stock-basedCompensation 24 false false R25.htm 00000025 - Disclosure - Income Tax (Tables) Sheet http://kiwabiotech.com/role/IncomeTaxTables Income Tax (Tables) Tables http://kiwabiotech.com/role/IncomeTax 25 false false R26.htm 00000026 - Disclosure - Description of Business and Organization (Details Narrative) Sheet http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganizationDetailsNarrative Description of Business and Organization (Details Narrative) Details http://kiwabiotech.com/role/DescriptionOfBusinessAndOrganization 26 false false R27.htm 00000027 - Disclosure - Going Concern (Details Narrative) Sheet http://kiwabiotech.com/role/GoingConcernDetailsNarrative Going Concern (Details Narrative) Details http://kiwabiotech.com/role/GoingConcern 27 false false R28.htm 00000028 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://kiwabiotech.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details 28 false false R29.htm 00000029 - Disclosure - Summary of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) Sheet http://kiwabiotech.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfForeignCurrencyExchangeRateDetails Summary of Significant Accounting Policies - Schedule of Foreign Currency Exchange Rate (Details) Details 29 false false R30.htm 00000030 - Disclosure - Prepaid expenses (Deatils Narrative) Sheet http://kiwabiotech.com/role/PrepaidExpensesDeatilsNarrative Prepaid expenses (Deatils Narrative) Uncategorized 30 false false R31.htm 00000031 - Disclosure - Advance to customer - Gerui (Details Narrative) Sheet http://kiwabiotech.com/role/AdvanceToCustomer-GeruiDetailsNarrative Advance to customer - Gerui (Details Narrative) Uncategorized 31 false false R32.htm 00000032 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://kiwabiotech.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Uncategorized 32 false false R33.htm 00000033 - Disclosure - Related Party Transactions - Schedule of Related Party Transactions (Details) Sheet http://kiwabiotech.com/role/RelatedPartyTransactions-ScheduleOfRelatedPartyTransactionsDetails Related Party Transactions - Schedule of Related Party Transactions (Details) Uncategorized 33 false false R34.htm 00000034 - Disclosure - Other Payable (Details Narrative) Sheet http://kiwabiotech.com/role/OtherPayableDetailsNarrative Other Payable (Details Narrative) Uncategorized 34 false false R35.htm 00000035 - Disclosure - Convertible Notes Payable (Details Narrative) Notes http://kiwabiotech.com/role/ConvertibleNotesPayableDetailsNarrative Convertible Notes Payable (Details Narrative) Uncategorized 35 false false R36.htm 00000036 - Disclosure - Note Payable (Details Narrative) Sheet http://kiwabiotech.com/role/NotePayableDetailsNarrative Note Payable (Details Narrative) Uncategorized 36 false false R37.htm 00000037 - Disclosure - Stockholders' Equity (Details Narrative) Sheet http://kiwabiotech.com/role/StockholdersEquityDetailsNarrative Stockholders' Equity (Details Narrative) Uncategorized 37 false false R38.htm 00000038 - Disclosure - Stock-based Compensation (Details Narrative) Sheet http://kiwabiotech.com/role/Stock-basedCompensationDetailsNarrative Stock-based Compensation (Details Narrative) Uncategorized 38 false false R39.htm 00000039 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation (Details) Sheet http://kiwabiotech.com/role/Stock-basedCompensation-ScheduleOfStock-basedCompensationDetails Stock-based Compensation - Schedule of Stock-based Compensation (Details) Uncategorized 39 false false R40.htm 00000040 - Disclosure - Stock-based Compensation - Schedule of Stock-based Compensation (Details) (Parenthetical) Sheet http://kiwabiotech.com/role/Stock-basedCompensation-ScheduleOfStock-basedCompensationDetailsParenthetical Stock-based Compensation - Schedule of Stock-based Compensation (Details) (Parenthetical) Uncategorized 40 false false R41.htm 00000041 - Disclosure - Commitments and Contingencies (Details Narrative) Sheet http://kiwabiotech.com/role/CommitmentsAndContingenciesDetailsNarrative Commitments and Contingencies (Details Narrative) Uncategorized 41 false false R42.htm 00000042 - Disclosure - Income Tax (Details Narrative) Sheet http://kiwabiotech.com/role/IncomeTaxDetailsNarrative Income Tax (Details Narrative) Uncategorized 42 false false R43.htm 00000043 - Disclosure - Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) Sheet http://kiwabiotech.com/role/IncomeTax-ScheduleOfReconciliationOfU.s.TaxRateDetails Income Tax - Schedule of Reconciliation of U.S. Tax Rate (Details) Uncategorized 43 false false R44.htm 00000044 - Disclosure - Income Tax - Schedule of Provision for Income Tax (Details) Sheet http://kiwabiotech.com/role/IncomeTax-ScheduleOfProvisionForIncomeTaxDetails Income Tax - Schedule of Provision for Income Tax (Details) Uncategorized 44 false false R45.htm 00000045 - Disclosure - Income Tax - Schedule of Deferred Tax Assets (Details) Sheet http://kiwabiotech.com/role/IncomeTax-ScheduleOfDeferredTaxAssetsDetails Income Tax - Schedule of Deferred Tax Assets (Details) Uncategorized 45 false false All Reports Book All Reports kwbt-20160930.xml kwbt-20160930.xsd kwbt-20160930_cal.xml kwbt-20160930_def.xml kwbt-20160930_lab.xml kwbt-20160930_pre.xml true true ZIP 63 0001493152-16-015332-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-16-015332-xbrl.zip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end